Revised. Amendments from Version 1
==================================

This version of the manuscript has been updated to address reviewer comments. Phenotype data has been added for wild-type control embryos and the effect of allele type on phenotype penetrance has been studied.

Introduction
============

Animal models have long been used as experimental surrogates for investigating the role of individual genes in human development and disease. The remarkable degree of conservation in gene sequence and role that we now know exists across species confirms the validity of this approach and genetic manipulation in the mouse provides a commonly used way to explore gene function. The most ambitious example of this is the attempt coordinated by the International Mouse Phenotyping Consortium (IMPC) to generate a catalogue of gene function, using a systematic approach to phenotyping of individual gene knockouts (KO) that cover the entire mouse genome. In generating KO lines from about one quarter of the total mouse genome so far, these studies have revealed that around one third of all mammalian genes are essential for life ^[@ref-1]--\ [@ref-3]^, their removal resulting in embryonic or perinatal lethality. The study of such mutant lines provides a unique opportunity to gain a comprehensive overview of the genetic components regulating normal embryo development and, by inference, the identity of genes whose mutation may cause congenital abnormalities or developmental disease.

Deciphering the Mechanisms of Developmental Disorders (DMDD) is a five year, UK-based programme funded by the Wellcome Trust with the goal of studying 240 embryonic lethal KO lines ^[@ref-3]^. By applying systematic phenotyping methods for homozygous mutant embryos with parallel efforts to identify placental abnormalities and changes in early embryo transcriptome profiles, DMDD offers a foundation for identifying novel genes important for developmental or clinical studies. Here we summarise results to date from detailed examination of homozygous mutant embryos at E14.5 for structural abnormalities.

Materials and methods
=====================

Embryos
-------

All embryos were produced by the Wellcome Trust Sanger Institute ( <https://www.sanger.ac.uk/mouseportal/>) as part of the DMDD project ^[@ref-3]^. Gene knockout lines produced as part of a systematic programme coordinated by the International Mouse Phenotyping Consortium ( <http://www.mousephenotype.org>) were designated lethal if no homozygous mutants were present amongst a minimum of 28 pups at P14 and sub-viable if their proportion fell below 13% of total offspring ^[@ref-2]^. All embryos are obtained from heterozygous intercross independently from the P14 viability call. Embryos were harvested from one or more litters at E14.5, fixed in Bouin's fixative for 24 hours and stored at 4°C in phosphate buffered saline.

Generation of digital volume data
---------------------------------

Embryos were initially scored for gross abnormalities under a dissection microscope before preparation for 3D imaging. Briefly, embryos were dehydrated in methanol (10% steps until 90%, followed by 95% and 100%; at least 2 hours each) and embedded in methacrylate resin (JB-4, PolySciences) containing eosin B and acridine orange, as previously described ^[@ref-4]--\ [@ref-6]^. Within each resin block, the embryo was oriented to ensure transverse sectioning along its longitudinal axis. Resin blocks were allowed to polymerise overnight at room temperature, baked at 90°C for 24--48 hours and then subjected to digital volume data generation using high-resolution episcopic microscopy (HREM) ^[@ref-7]^. HREM data was downsized as appropriate to provide an isotropic voxel size of between 2.5--3 µm, depending on original section thickness.

Data processing and annotation
------------------------------

12 bit raw greyscale image data was adjusted to optimise tissue visualisation using Photoshop 6 (Adobe). Data visualisation and analysis was performed using software packages Amira 5 (ThermoFisher Scientific) and Osirix, versions 6--8 (Pixmeo). Phenotypes were identified by establishing the precise developmental sub-stage of each embryo and comparing it with stage-matched controls ^[@ref-8]^. Phenotyping was performed according to a standardised and sequential procedure using actual and virtual 2D section stacks, essentially as recently described ^[@ref-9]^. Data from each embryo was independently reviewed by a second anatomist, and any discrepancies resolved by joint agreement. Each phenotype call was assigned to a 3D point within the embryo image data stack. Abnormalities were classified with the Mammalian Phenotype (MP) ontology ^[@ref-10]^, using the most specific MP term that described each defect. 3D volume rendered models were employed for developmental staging from external morphology ^[@ref-8]^.

Data analysis
-------------

In order to facilitate summarising of detailed phenotype annotation data, two subsets of the MP terms closer to the root of the ontology were chosen to provide structured "high" and "intermediate" level overviews of DMDD phenotype data. These MP ontology slims are shown in [Table 5](#T5){ref-type="table"} and [Table 6](#T6){ref-type="table"} ( [Supplementary Table 2](#ST2){ref-type="other"} and [Supplementary 3](#ST3){ref-type="other"} for download). The MP terms assigned during annotation of the embryos were summarised into the categories defined by the DMDD slims using the Map2Slim algorithm ( <https://metacpan.org/pod/distribution/go-perl/scripts/map2slim>). All the terms of the DMDD slims that map to terms used to annotate mutant and wild type embryo phenotypes are listed in [Supplementary Table 1A](#ST1aa){ref-type="other"} and [Supplementary Table 1B](#ST1aa){ref-type="other"}, respectively.

MP annotation terms used to describe the phenotypes of each embryo of a line were normalised to remove duplicate terms, and the terms for each embryo were mapped onto the ontology slims. For each line, a set of the unique slim terms observed for the line was generated and lists were produced of all the embryos from the line falling into each of these high or intermediate level categories. This enabled calculation of a penetrance score for each of the broad slim terms, calculated as a ratio of the number of embryos listed for the slim category to the number of homozygous mutant embryos analysed for the line.

To obtain a global view of the phenotypes detected, the frequency of lines showing each of the broad category slim terms were counted across all the lines analysed. In addition, the incidence of embryos scored for every phenotype category described by the slim terms, and the total number of embryos analysed in lines exhibiting each individual phenotype category was counted.

The total number of lines for each slim term that had a penetrance score between 0--0.24, 0.25--0.49, 0.50--0.74 and 0.75--1.00 was recorded. We calculated the cumulative penetrance score for each slim term as the overall sum of the penetrance scores of every line showing this broad category phenotype. In addition, for each of the penetrance intervals listed above, the sum of the penetrance scores was calculated for the lines falling into these categories.

All plots showing analysis of the data were produced using the R software package, version 3.2.1 (2015-06-18) (The R Foundation for Statistical Computing).

Use of animals
--------------

The care and use of all mice in this study were in accordance with UK Home Office regulations, UK Animals (Scientific Procedures) Act of 1986 (PPL 80/2485) and were approved by the Wellcome Trust Sanger Institute's Animal Welfare and Ethical Review Body.

Results
=======

Size of the study
-----------------

The data for this study comprises 220 homozygous mutant and 114 wild type E14.5 embryos analysed by the DMDD programme. All data is presented in [Supplementary Table 4](#ST4){ref-type="other"} and [Supplementary Table 5](#ST5){ref-type="other"} and is and also available on the DMDD web site ( <https://dmdd.org.uk>). Embryos were obtained from 42 novel gene knockout lines, 31 classified as lethal and 11 as sub-viable ( [Table 1](#T1){ref-type="table"}; see also Materials and methods). This corresponds to an average of approximately 5 homozygous mutant embryos for each mutant line, although in practice numbers ranged widely from 1 to 11 as a result of variable breeding efficiency and cost limitations inherent in a large scale screening programme ( [Supplementary Figure 1](#SF1){ref-type="other"}). In total, 1,128,247 transverse section images obtained from the 334 embryos formed the basis for examining embryo structure and with the addition of digital resection of datasets in coronal and sagittal planes, scoring of phenotypes was based on examination of 2,536,659 images.

###### List of lethal and subviable lines studied.

The gene symbol, Mouse Genome Informatics (MGI) ID for the gene, and allele symbol is listed for each line studied along with the number of homozygous mutant embryos analysed, genetic background and the viability status.

  ----------------------------------------------------------------------------------------------------------------------------------------
  Gene              MGI ID        Allele                              P14\          E14.5\        E14.5\       Genetic Background
                                                                      homozygous\   homozygous\   wild type\   
                                                                      viability     mutant\       embryos\     
                                                                                    embryos\      analysed     
                                                                                    analysed                   
  ----------------- ------------- ----------------------------------- ------------- ------------- ------------ ---------------------------
  *1700067K01Rik*   MGI:1920703   1700067K01Rik\<tm2a(KOMP)Wtsi\>     Lethal        8             2            C57BL/6N;C57BL/6NTac

  *4933434E20Rik*   MGI:1914027   4933434E20Rik\<tm1a(EUCOMM)Wtsi\>   Lethal        6             3            C57BL/6N;C57BL/6NTac

  *Adamts3*         MGI:3045353   Adamts3\<tm1b(KOMP)Wtsi\>           Lethal        7             3            C57BL/6N;C57BL/6NTac

  *Adcy9*           MGI:108450    Adcy9\<tm1b(EUCOMM)Wtsi\>           Subviable     8             3            C57BL/6N;C57BL/6NTac

  *Anks6*           MGI:1922941   Anks6\<tm1b(KOMP)Wtsi\>             Lethal        2             3            C57BL/6N;C57BL/6NTac

  *Atp11a*          MGI:1354735   Atp11a\<tm1a(KOMP)Wtsi\>            Lethal        5             2            C57BL/6N;C57BL/6NTac

  *Brd2*            MGI:99495     Brd2\<em2Wtsi\>                     Lethal        5             3            C57BL/6NTac

  *Camsap3*         MGI:1916947   Camsap3\<tm1a(EUCOMM)Wtsi\>         Subviable     4             3            C57BL/6N;C57BL/6NTac

  *Celf4*           MGI:1932407   Celf4\<tm1a(EUCOMM)Wtsi\>           Lethal        5             3            C57BL/6N;C57BL/6NTac

  *Chst11*          MGI:1927166   Chst11\<tm1a(KOMP)Wtsi\>            Lethal        10            2            C57BL/6N;C57BL/6NTac

  *Chtop*           MGI:1913761   Chtop\<tm1a(EUCOMM)Wtsi\>           Lethal        4             3            C57BL/6N;C57BL/6NTac

  *Cir1*            MGI:1914185   Cir1\<tm3a(KOMP)Wtsi\>              Lethal        3             2            C57BL/6N;C57BL/6NTac

  *Cmip*            MGI:1921690   Cmip\<tm1a(EUCOMM)Wtsi\>            Lethal        10            5            C57BL/6N;C57BL/6NTac

  *Col4a3bp*        MGI:1915268   Col4a3bp\<tm1a(KOMP)Wtsi\>          Subviable     2             3            C57BL/6N;C57BL/6NTac

  *Cpt2*            MGI:109176    Cpt2\<tm1b(KOMP)Wtsi\>              Subviable     6             3            C57BL/6N;C57BL/6NTac

  *D930028M14Rik*   MGI:3687343   D930028M14Rik\<tm1a(EUCOMM)Wtsi\>   Lethal        5             3            C57BL/6N;C57BL/6NTac

  *Dbn1*            MGI:1931838   Dbn1\<tm1b(KOMP)Wtsi\>              Subviable     5             2            C57BL/6N;C57BL/6NTac

  *Dhx35*           MGI:1918965   Dhx35\<tm1b(EUCOMM)Wtsi\>           Lethal        1             2            C57BL/6N;C57BL/6NTac

  *Exoc3l2*         MGI:1921713   Exoc3l2\<tm1b(KOMP)Wtsi\>           Lethal        3             4            C57BL/6N;C57BL/6NTac

  *Fam46c*          MGI:1921895   Fam46c\<tm1b(KOMP)Wtsi\>            Lethal        8             3            C57BL/6N;C57BL/6NTac

  *H13*             MGI:95886     H13\<tm1b(KOMP)Wtsi\>               Lethal        7             3            C57BL/6N;C57BL/6NTac

  *Kif1bp*          MGI:1919570   Kif1bp\<tm1a(KOMP)Wtsi\>            Lethal        3             2            C57BL/6N;C57BL/6NTac

  *Mybphl*          MGI:1916003   Mybphl\<tm1b(KOMP)Wtsi\>            Subviable     3             5            C57BL/6N;C57BL/6NTac

  *Npat*            MGI:107605    Npat\<tm1b(EUCOMM)Wtsi\>            Lethal        1             1            C57BL/6N;C57BL/6NTac

  *Nsun2*           MGI:107252    Nsun2\<tm1a(EUCOMM)Wtsi\>           Subviable     6             2            C57BL/6Brd-Tyr\<c-Brd\>;\
                                                                                                               C57BL/6Dnk;\
                                                                                                               C57BL/6N;C57BL/6NTac

  *Nxn*             MGI:109331    Nxn\<tm1b(EUCOMM)Wtsi\>             Lethal        3             3            C57BL/6N;C57BL/6NTac

  *Otud7b*          MGI:2654703   Otud7b\<tm1b(EUCOMM)Wtsi\>          Lethal        1             3            C57BL/6N;C57BL/6NTac

  *Pdzk1*           MGI:1928901   Pdzk1\<tm2b(EUCOMM)Wtsi\>           Subviable     9             3            C57BL/6N;C57BL/6NTac

  *Polb*            MGI:97740     Polb\<tm1a(KOMP)Wtsi\>              Lethal        6             1            C57BL/6N;C57BL/6NTac

  *Prrc2b*          MGI:1923304   Prrc2b\<tm1a(EUCOMM)Wtsi\>          Lethal        9             4            C57BL/6N;C57BL/6NTac

  *Psph*            MGI:97788     Psph\<tm1a(EUCOMM)Hmgu\>            Lethal        8             3            C57BL/6N;C57BL/6NTac

  *Pth1r*           MGI:97801     Pth1r\<tm1a(EUCOMM)Hmgu\>           Lethal        3             3            C57BL/6N;C57BL/6NTac

  *Rundc1*          MGI:2144506   Rundc1\<tm1b(EUCOMM)Wtsi\>          Subviable     4             1            C57BL/6N;C57BL/6NTac

  *Sh3pxd2a*        MGI:1298393   Sh3pxd2a\<tm1b(EUCOMM)Wtsi\>        Lethal        11            2            C57BL/6N;C57BL/6NTac

  *Slc25a20*        MGI:1928738   Slc25a20\<tm1a(EUCOMM)Wtsi\>        Lethal        6             4            C57BL/6N;C57BL/6NTac

  *Slc5a7*          MGI:1927126   Slc5a7\<tm1a(KOMP)Wtsi\>            Lethal        3             3            C57BL/6N;C57BL/6NTac

  *Smg9*            MGI:1919247   Smg9\<tm1b(EUCOMM)Wtsi\>            Lethal        6             3            C57BL/6N;C57BL/6NTac

  *Smpd4*           MGI:1924876   Smpd4\<tm2b(KOMP)Wtsi\>             Subviable     3             1            C57BL/6N;C57BL/6NTac

  *Ssr2*            MGI:1913506   Ssr2\<tm1b(EUCOMM)Wtsi\>            Lethal        3             0            C57BL/6N;C57BL/6NTac

  *Tcf7l2*          MGI:1202879   Tcf7l2\<tm1a(EUCOMM)Wtsi\>          Lethal        5             4            C57BL/6N;C57BL/6NTac

  *Traf6*           MGI:108072    Traf6\<tm2a(EUCOMM)Wtsi\>           Lethal        9             5            C57BL/6N;C57BL/6NTac

  *Unk*             MGI:2442456   Unk\<tm1a(KOMP)Wtsi\>               Subviable     5             2            C57BL/6N;C57BL/6NTac
  ----------------------------------------------------------------------------------------------------------------------------------------

Incidence of structural abnormalities in homozygous mutant embryos
------------------------------------------------------------------

Almost all mutant embryos studied (209/220) showed structural abnormalities that could be identified by a phenotyping procedure previously refined from pilot studies ^[@ref-9]^. The remaining 11 apparently normal embryos were obtained from 9 different lines, each of which yielded several other homozygous mutants bearing detectable morphological abnormalities. We have previously reported that the resolution afforded by 3D datasets obtained by HREM imaging allowed the detection of phenotypic abnormalities spanning in size range from individual nerves and blood vessels to gross organ and tissue malformations ^[@ref-9]^. In the present study, a total of 398 different MP terms were employed to record a total of 2,939 detected mutant embryo phenotypes ( [Table 2A](#T2a){ref-type="table"} and [Supplementary Table 1A](#ST1a){ref-type="other"} and [Supplementary Table 4](#ST4){ref-type="other"}). Multiple abnormalities were scored in virtually all homozygous mutant embryos. Most showed up to 10, but in some embryos as many as 50 phenotypes were recorded ( [Figure 1A](#f1){ref-type="fig"}). Whilst a few phenotypes (for example those affecting different parts of vertebrae or different regions of the vertebral column) were often scored repeatedly within affected embryos, their incidence was insufficient to have a significant impact on the overall distribution of phenotype numbers scored per embryo across the whole study. When analysed by individual mutant line, the incidence of detectable abnormalities is more broadly distributed, with more than half of the 42 lines showing between 10 and 49 different phenotypes ( [Figure 1B](#f1){ref-type="fig"}).

###### Frequency of phenotypes identified in homozygous mutant embryos.

The Mammalian Phenotype Ontology terms describing phenotypes observed in each embryo were normalised to remove duplicates and the list then ranked in descending order by frequency of embryos exhibiting each phenotype.

  -----------------------------------------------------------------
  MP ID        MP term                                  Frequency
  ------------ ---------------------------------------- -----------
  MP:0013848   subcutaneous edema                       64

  MP:0004613   fusion of vertebral arches               61

  MP:0010418   perimembraneous ventricular septal\      49
               defect                                   

  MP:0000783   abnormal forebrain morphology            47

  MP:0003686   abnormal eye muscle morphology           45

  MP:0001015   small superior cervical ganglion         45

  MP:0010420   muscular ventricular septal defect       41

  MP:0013835   absent hypoglossal nerve                 37

  MP:0003826   abnormal Mullerian duct\                 33
               morphology                               

  MP:0014021   heterochrony                             33

  MP:0004269   abnormal optic cup morphology            32

  MP:0014001   abnormal vertebral artery topology       32

  MP:0013836   abnormal hypoglossal nerve\              30
               topology                                 

  MP:0013876   absent ductus venosus valve              29

  MP:0000284   double outlet right ventricle            29

  MP:0004666   absent stapedial artery                  28

  MP:0013971   blood in lymph vessels                   27

  MP:0000703   abnormal thymus morphology               26

  MP:0014000   anastomosis between internal\            25
               carotid artery and basilar artery        

  MP:0000602   enlarged liver sinusoidal spaces         25

  MP:0013969   reduced sympathetic cervical\            25
               ganglion size                            

  MP:0008923   thoracoschisis                           25

  MP:0004163   abnormal adenohypophysis\                24
               morphology                               

  MP:0002237   abnormal nasal cavity morphology         20

  MP:0013986   abnormal vitelline vein topology         20

  MP:0013967   abnormal infrahyoid muscle\              18
               connection                               

  MP:0004463   basisphenoid bone foramen                18

  MP:0008128   abnormal brain internal capsule\         16
               morphology                               

  MP:0000282   abnormal interatrial septum\             16
               morphology                               

  MP:0004268   abnormal optic stalk morphology          16

  MP:0013936   abnormal thymus topology                 16

  MP:0014017   abnormal Wolffian duct connection        15

  MP:0013877   abnormal ductus venosus valve\           15
               morphology                               

  MP:0002239   abnormal nasal septum morphology         15

  MP:0000497   abnormal small intestine placement       15

  MP:0000111   cleft palate                             15

  MP:0013859   abnormal vitelline vein connection       14

  MP:0013826   absent hypoglossal canal                 14

  MP:0013840   absent segment of posterior\             14
               cerebral artery                          

  MP:0013875   trigeminal neuroma                       14

  MP:0010496   abnormal pectinate muscle\               13
               morphology                               

  MP:0013834   thin hypoglossal nerve                   13

  MP:0003827   abnormal Wolffian duct morphology        12

  MP:0013842   ductus venosus stenosis                  12

  MP:0010912   herniated liver                          12

  MP:0013968   multiple persisting craniopharyngeal\    12
               ducts                                    

  MP:0011361   pelvic kidney                            12

  MP:0010572   persistent right dorsal aorta            12

  MP:0002633   persistent truncus arteriosis            12

  MP:0013931   abnormal olfactory bulb position         11

  MP:0011683   dual inferior vena cava                  11

  MP:0000914   exencephaly                              11

  MP:0002169   no abnormal phenotype detected           11

  MP:0000154   rib fusion                               11

  MP:0000161   scoliosis                                11

  MP:0004110   transposition of great arteries          11

  MP:0012303   umbilical vein stenosis                  11

  MP:0008922   abnormal cervical rib                    10

  MP:0009917   abnormal hyoid bone body\                10
               morphology                               

  MP:0009770   abnormal optic chiasm morphology         10

  MP:0013844   abnormal perichondrial ossification      10

  MP:0003345   decreased rib number                     10

  MP:0011493   double ureter                            10

  MP:0000445   short snout                              10

  MP:0002951   small thyroid gland                      10

  MP:0013878   abnormal ductus venosus valve\           9
               topology                                 

  MP:0000841   abnormal hindbrain morphology            9

  MP:0010490   abnormal inferior vena cava valve\       9
               morphology                               

  MP:0010853   abnormal lung position or\               9
               orientation                              

  MP:0000141   abnormal vertebral body\                 9
               morphology                               

  MP:0002243   abnormal vomeronasal organ\              9
               morphology                               

  MP:0013970   absent connection between\               9
               subcutaneous lymph vessels and\          
               lymph sac                                

  MP:0011667   double outlet right ventricle with\      9
               atrioventricular septal defect           

  MP:0014019   embryo cyst                              9

  MP:0013977   symmetric azygos veins                   9

  MP:0002092   abnormal eye morphology                  8

  MP:0014023   abnormal intestine placement             8

  MP:0001303   abnormal lens morphology                 8

  MP:0000632   abnormal pineal gland morphology         8

  MP:0010602   abnormal pulmonary valve cusp\           8
               morphology                               

  MP:0013985   abnormal umbilical vein topology         8

  MP:0013965   abnormally deep median sulcus of\        8
               tongue                                   

  MP:0010484   bicuspid aortic valve                    8

  MP:0004646   decreased cervical vertebrae\            8
               number                                   

  MP:0013915   abnormal brachial plexus formation       7

  MP:0010436   abnormal coronary sinus\                 7
               morphology                               

  MP:0000819   abnormal olfactory bulb\                 7
               morphology                               

  MP:0009570   abnormal right lung morphology           7

  MP:0003078   aphakia                                  7

  MP:0003584   bifid ureter                             7

  MP:0013949   fusion of axis and occipital bones       7

  MP:0013846   retropharyngeal edema                    7

  MP:0013847   retropleural edema                       7

  MP:0000153   rib bifurcation                          7

  MP:0002191   abnormal artery morphology               6

  MP:0000079   abnormal basioccipital bone\             6
               morphology                               

  MP:0000788   abnormal cerebral cortex\                6
               morphology                               

  MP:0013995   abnormal external carotid artery\        6
               origin                                   

  MP:0013845   abnormal eye muscle topology             6

  MP:0002858   abnormal posterior semicircular\         6
               canal morphology                         

  MP:0000759   abnormal skeletal muscle\                6
               morphology                               

  MP:0013871   abnormal stapedial artery topology       6

  MP:0001146   abnormal testis morphology               6

  MP:0000681   abnormal thyroid gland morphology        6

  MP:0004599   abnormal vertebral arch\                 6
               morphology                               

  MP:0013996   abnormal vertebral artery origin         6

  MP:0013849   absent abducens nerve                    6

  MP:0000520   absent kidney                            6

  MP:0009725   absent lens vesicle                      6

  MP:0006093   arteriovenous malformation               6

  MP:0010412   atrioventricular septal defect           6

  MP:0013932   fragmented Meckel\'s cartilage           6

  MP:0000963   fused dorsal root ganglion               6

  MP:0005157   holoprosencephaly                        6

  MP:0000480   increased rib number                     6

  MP:0013992   persistent dorsal ophthalmic artery      6

  MP:0013952   retro-esophageal left subclavian\        6
               artery                                   

  MP:0004160   retroesophageal right subclavian\        6
               artery                                   

  MP:0004158   right aortic arch                        6

  MP:0020301   short tongue                             6

  MP:0002989   small kidney                             6

  MP:0013852   abnormal Mullerian duct topology         5

  MP:0010595   abnormal aortic valve cusp\              5
               morphology                               

  MP:0000297   abnormal atrioventricular cushion\       5
               morphology                               

  MP:0013186   abnormal basilar artery morphology       5

  MP:0002152   abnormal brain morphology                5

  MP:0013874   abnormal ductus venosus topology         5

  MP:0013945   abnormal elbow joint morphology          5

  MP:0000559   abnormal femur morphology                5

  MP:0006063   abnormal inferior vena cava\             5
               morphology                               

  MP:0002135   abnormal kidney morphology               5

  MP:0001879   abnormal lymphatic vessel\               5
               morphology                               

  MP:0005236   abnormal olfactory nerve\                5
               morphology                               

  MP:0000150   abnormal rib morphology                  5

  MP:0004539   absent maxilla                           5

  MP:0003451   absent olfactory bulb                    5

  MP:0001014   absent superior cervical ganglion        5

  MP:0014003   additional anastomosis between\          5
               intracranial vertebral arteries          

  MP:0012548   myelocele                                5

  MP:0000273   overriding aortic valve                  5

  MP:0000964   small dorsal root ganglion               5

  MP:0000694   spleen hypoplasia                        5

  MP:0013928   thin motoric part of trigeminal nerve    5

  MP:0002199   abnormal brain commissure\               4
               morphology                               

  MP:0006065   abnormal heart position or\              4
               orientation                              

  MP:0002249   abnormal larynx morphology               4

  MP:0009820   abnormal liver vasculature\              4
               morphology                               

  MP:0005105   abnormal middle ear ossicle\             4
               morphology                               

  MP:0004164   abnormal neurohypophysis\                4
               morphology                               

  MP:0013994   abnormal parasellar internal carotid\    4
               artery branch morphology                 

  MP:0000633   abnormal pituitary gland\                4
               morphology                               

  MP:0013980   abnormal pulmonary artery origin         4

  MP:0011655   abnormal systemic artery\                4
               morphology                               

  MP:0011513   abnormal vertebral artery\               4
               morphology                               

  MP:0013855   absent celiac artery                     4

  MP:0013833   absent olfactory nerve                   4

  MP:0013362   absent pineal gland                      4

  MP:0014006   absent posterior communicating\          4
               artery                                   

  MP:0013913   absent rib-vertebral column\             4
               attachment                               

  MP:0004846   absent skeletal muscle                   4

  MP:0004603   absent vertebral arch                    4

  MP:0010440   anomalous pulmonary venous\              4
               connection                               

  MP:0010530   cerebral arteriovenous malformation      4

  MP:0010589   common truncal valve                     4

  MP:0003924   diaphragmatic hernia                     4

  MP:0003253   dilated bile duct                        4

  MP:0013879   duplication of ductus venosus            4

  MP:0008534   enlarged fourth ventricle                4

  MP:0004612   fusion of vertebral bodies               4

  MP:0001914   hemorrhage                               4

  MP:0003262   intestinal/bowel diverticulum            4

  MP:0010404   ostium primum atrial septal defect       4

  MP:0013917   persistent right 6th pharyngeal arch\    4
               artery                                   

  MP:0000562   polydactyly                              4

  MP:0001088   small nodose ganglion                    4

  MP:0013827   thin oculomotor nerve                    4

  MP:0013858   abnormal azygos vein topology            3

  MP:0002928   abnormal bile duct morphology            3

  MP:0008026   abnormal brain white matter\             3
               morphology                               

  MP:0004607   abnormal cervical atlas morphology       3

  MP:0000820   abnormal choroid plexus\                 3
               morphology                               

  MP:0013873   abnormal ductus venosus\                 3
               morphology                               

  MP:0010439   abnormal hepatic vein morphology         3

  MP:0000823   abnormal lateral ventricle\              3
               morphology                               

  MP:0000598   abnormal liver morphology                3

  MP:0000897   abnormal midbrain morphology             3

  MP:0013861   abnormal pancreas topology               3

  MP:0000613   abnormal salivary gland\                 3
               morphology                               

  MP:0013943   abnormal ureter topology                 3

  MP:0001100   abnormal vagus ganglion\                 3
               morphology                               

  MP:0014002   absent extracranial vertebral artery\    3
               segment                                  

  MP:0013929   absent eye muscles                       3

  MP:0003722   absent ureter                            3

  MP:0000138   absent vertebrae                         3

  MP:0000640   adrenal gland hypoplasia                 3

  MP:0005262   coloboma                                 3

  MP:0010433   double inlet heart left ventricle        3

  MP:0001785   edema                                    3

  MP:0000274   enlarged heart                           3

  MP:0006203   eye hemorrhage                           3

  MP:0005244   hemopericardium                          3

  MP:0013843   hepatic portal vein stenosis             3

  MP:0011659   interrupted aortic arch, type b          3

  MP:0013948   intraembryonal intestine elongation      3

  MP:0013963   jugular vein stenosis                    3

  MP:0000692   small spleen                             3

  MP:0001093   small trigeminal ganglion                3

  MP:0013828   thin facial nerve                        3

  MP:0004057   thin myocardium compact layer            3

  MP:0003617   urinary bladder hypoplasia               3

  MP:0013851   abnormal Wolffian duct topology          2

  MP:0013857   abnormal abdominal muscle\               2
               morphology                               

  MP:0004113   abnormal aortic arch morphology          2

  MP:0002747   abnormal aortic valve morphology         2

  MP:0004181   abnormal carotid artery morphology       2

  MP:0013978   abnormal carotid artery origin           2

  MP:0013975   abnormal coronary sinus\                 2
               connection                               

  MP:0002279   abnormal diaphragm morphology            2

  MP:0013815   abnormal digastric muscle\               2
               morphology                               

  MP:0013865   abnormal dorsal pancreas topology        2

  MP:0000961   abnormal dorsal root ganglion\           2
               morphology                               

  MP:0013950   abnormal dorsal root ganglion\           2
               topology                                 

  MP:0006011   abnormal endolymphatic duct\             2
               morphology                               

  MP:0013918   abnormal endolymphatic sac\              2
               topology                                 

  MP:0006033   abnormal external auditory canal\        2
               morphology                               

  MP:0000266   abnormal heart morphology                2

  MP:0003056   abnormal hyoid bone morphology           2

  MP:0013966   abnormal infrahyoid muscle\              2
               morphology                               

  MP:0000489   abnormal large intestine\                2
               morphology                               

  MP:0008986   abnormal liver parenchyma\               2
               morphology                               

  MP:0001175   abnormal lung morphology                 2

  MP:0000458   abnormal mandible morphology             2

  MP:0003632   abnormal nervous system\                 2
               morphology                               

  MP:0001330   abnormal optic nerve morphology          2

  MP:0002177   abnormal outer ear morphology            2

  MP:0000492   abnormal rectum morphology               2

  MP:0002428   abnormal semicircular canal\             2
               morphology                               

  MP:0002746   abnormal semilunar valve\                2
               morphology                               

  MP:0000496   abnormal small intestine\                2
               morphology                               

  MP:0005107   abnormal stapes morphology               2

  MP:0003230   abnormal umbilical artery\               2
               morphology                               

  MP:0002725   abnormal vein morphology                 2

  MP:0009707   absent external auditory canal           2

  MP:0013987   absent intrahepatic inferior vena\       2
               cava segment                             

  MP:0009771   absent optic chiasm                      2

  MP:0013999   absent parasellar internal carotid\      2
               artery                                   

  MP:0013809   absent pectinate muscle                  2

  MP:0004571   absent vagus nerve                       2

  MP:0000140   absent vertebral pedicles                2

  MP:0003130   anal atresia                             2

  MP:0010463   aorta stenosis                           2

  MP:0004055   atrium hypoplasia                        2

  MP:0010406   common atrium                            2

  MP:0003586   dilated ureter                           2

  MP:0013981   double lumen aortic arch                 2

  MP:0014018   embryo tumor                             2

  MP:0010200   enlarged lymphatic vessel                2

  MP:0008536   enlarged third ventricle                 2

  MP:0002015   epithelioid cysts                        2

  MP:0004201   fetal growth retardation                 2

  MP:0010977   fused right lung lobes                   2

  MP:0010728   fusion of atlas and occipital bones      2

  MP:0013982   inverse situs of great intrathoracic\    2
               arteries                                 

  MP:0010647   left atrium hypoplasia                   2

  MP:0000600   liver hypoplasia                         2

  MP:0000618   small salivary gland                     2

  MP:0001102   small superior vagus ganglion            2

  MP:0000706   small thymus                             2

  MP:0011249   abdominal situs inversus                 1

  MP:0000639   abnormal adrenal gland\                  1
               morphology                               

  MP:0010592   abnormal atrioventricular septum\        1
               morphology                               

  MP:0002745   abnormal atrioventricular valve\         1
               morphology                               

  MP:0001614   abnormal blood vessel morphology         1

  MP:0000494   abnormal cecum morphology                1

  MP:0013862   abnormal cecum position                  1

  MP:0010744   abnormal cervical flexure\               1
               morphology                               

  MP:0003048   abnormal cervical vertebrae\             1
               morphology                               

  MP:0009495   abnormal common bile duct\               1
               morphology                               

  MP:0012729   abnormal common carotid artery\          1
               morphology                               

  MP:0013930   abnormal digastric muscle\               1
               connection                               

  MP:0004252   abnormal direction of heart looping      1

  MP:0014022   abnormal duodenum topology               1

  MP:0013924   abnormal dural venous sinus\             1
               morphology                               

  MP:0013927   abnormal facial nerve topology           1

  MP:0006107   abnormal fetal atrioventricular canal\   1
               morphology                               

  MP:0000828   abnormal fourth ventricle\               1
               morphology                               

  MP:0005084   abnormal gallbladder morphology          1

  MP:0003105   abnormal heart atrium morphology         1

  MP:0003922   abnormal heart right atrium\             1
               morphology                               

  MP:0013814   abnormal hepatic portal vein\            1
               connection                               

  MP:0013853   abnormal hepatic portal vein\            1
               formation                                

  MP:0010668   abnormal hepatic portal vein\            1
               morphology                               

  MP:0013973   abnormal hepatic vein connection         1

  MP:0005296   abnormal humerus morphology              1

  MP:0009913   abnormal hyoid bone greater horn\        1
               morphology                               

  MP:0013824   abnormal hypoglossal canal\              1
               morphology                               

  MP:0002859   abnormal inner ear canal fusion          1

  MP:0009804   abnormal interventricular foramen\       1
               morphology                               

  MP:0000281   abnormal interventricular septum\        1
               morphology                               

  MP:0000477   abnormal intestine morphology            1

  MP:0013976   abnormal left vena cava superior\        1
               connection                               

  MP:0004881   abnormal lung size                       1

  MP:0013841   abnormal lymphatic vessel topology       1

  MP:0003792   abnormal major salivary gland\           1
               morphology                               

  MP:0000455   abnormal maxilla morphology              1

  MP:0000452   abnormal mouth morphology                1

  MP:0002108   abnormal muscle morphology               1

  MP:0004056   abnormal myocardium compact\             1
               layer morphology                         

  MP:0005269   abnormal occipital bone\                 1
               morphology                               

  MP:0013818   abnormal oral cavity morphology          1

  MP:0014011   abnormal ovary tissue architecture       1

  MP:0004509   abnormal pelvic girdle bone\             1
               morphology                               

  MP:0002748   abnormal pulmonary valve\                1
               morphology                               

  MP:0009571   abnormal right lung accessory lobe\      1
               morphology                               

  MP:0009688   abnormal spinal cord central canal\      1
               morphology                               

  MP:0008023   abnormal styloid process\                1
               morphology                               

  MP:0013979   abnormal subclavian artery origin        1

  MP:0001011   abnormal superior cervical ganglion\     1
               morphology                               

  MP:0000787   abnormal telencephalon\                  1
               morphology                               

  MP:0005272   abnormal temporal bone\                  1
               morphology                               

  MP:0000826   abnormal third ventricle\                1
               morphology                               

  MP:0002368   abnormal thymus capsule\                 1
               morphology                               

  MP:0002282   abnormal trachea morphology              1

  MP:0001065   abnormal trigeminal nerve\               1
               morphology                               

  MP:0010667   abnormal umbilical vein\                 1
               morphology                               

  MP:0000534   abnormal ureter morphology               1

  MP:0013925   abnormal vascular plexus formation       1

  MP:0000137   abnormal vertebrae morphology            1

  MP:0005274   abnormal viscerocranium\                 1
               morphology                               

  MP:0010666   abnormal vitelline vein morphology       1

  MP:0014004   absent basilar artery segment            1

  MP:0008129   absent brain internal capsule            1

  MP:0013998   absent canalicular internal carotid\     1
               artery segment                           

  MP:0008460   absent dorsal root ganglion              1

  MP:0013880   absent ductus venosus                    1

  MP:0013914   absent intracranial segment of\          1
               vertebral artery                         

  MP:0013937   absent lobe of thyroid gland             1

  MP:0000629   absent mammary gland                     1

  MP:0013926   absent neurohypophysis                   1

  MP:0013988   absent portal vein segment               1

  MP:0013850   absent posterior commissure              1

  MP:0000614   absent salivary gland                    1

  MP:0013823   absent segment of anterior cerebral\     1
               artery                                   

  MP:0000690   absent spleen                            1

  MP:0008386   absent styloid process                   1

  MP:0002728   absent tibia                             1

  MP:0009905   absent tongue                            1

  MP:0001064   absent trochlear nerve                   1

  MP:0013595   absent vomeronasal organ                 1

  MP:0013860   anastomosis between common\              1
               carotid and vertebral artery             

  MP:0014009   anastomosis between middle\              1
               cerebral arteries                        

  MP:0001293   anophthalmia                             1

  MP:0003387   aorta coarctation                        1

  MP:0006135   artery stenosis                          1

  MP:0000705   athymia                                  1

  MP:0010403   atrial septal defect                     1

  MP:0013935   basal brain tissue herniation            1

  MP:0010527   bicuspid pulmonary valve                 1

  MP:0011797   blind ureter                             1

  MP:0010607   common atrioventricular valve            1

  MP:0004686   decreased length of long bones           1

  MP:0009532   decreased parotid gland size             1

  MP:0004648   decreased thoracic vertebrae\            1
               number                                   

  MP:0011965   decreased total retina thickness         1

  MP:0001247   dermal cysts                             1

  MP:0000825   dilated lateral ventricles               1

  MP:0009144   dilated pancreatic duct                  1

  MP:0004938   dilated vasculature                      1

  MP:0011380   enlarged brain ventricles                1

  MP:0013864   enlarged paraumbilical vein              1

  MP:0003595   epididymal cyst                          1

  MP:0002947   increased hemangioma incidence           1

  MP:0001634   internal hemorrhage                      1

  MP:0011974   intestinal stenosis                      1

  MP:0001916   intracerebral hemorrhage                 1

  MP:0003178   left pulmonary isomerism                 1

  MP:0013953   left sided brachiocephalic trunk         1

  MP:0003327   liver cysts                              1

  MP:0003888   liver hemorrhage                         1

  MP:0000162   lordosis                                 1

  MP:0010854   lung situs inversus                      1

  MP:0005287   narrow eye opening                       1

  MP:0004442   occipital bone foramen                   1

  MP:0000565   oligodactyly                             1

  MP:0006221   optic nerve hypoplasia                   1

  MP:0013933   short Meckel\'s cartilage                1

  MP:0002766   situs inversus                           1

  MP:0002768   small adrenal glands                     1

  MP:0001306   small lens                               1

  MP:0013923   small prevertebral sympathetic\          1
               ganglia                                  

  MP:0006254   thin cerebral cortex                     1

  MP:0013829   thin splanchnic nerve                    1

  MP:0013832   thin vagus nerve                         1

  MP:0003499   thyroid hypoplasia                       1

  MP:0009904   tongue hypoplasia                        1

  MP:0011697   vacuolated lens                          1

  MP:0013831   vagus nerve compression                  1

  MP:0004609   vertebral fusion                         1
  -----------------------------------------------------------------

![Multiple abnormalities are evident in homozygous mutant embryos.\
The Mammalian Phenotype Ontology terms scored for ( **A**) each embryo, and ( **B**) each line were normalised to remove duplicate ontology terms. The number of distinct phenotypes scored that fell into categories with a window width of 10 were plotted to show the total number of embryos and lines respectively in each category.](wellcomeopenres-1-11724-g0000){#f1}

Incidence of structural abnormalities in wild type embryos
----------------------------------------------------------

To establish the possible impact of "background" abnormalities present within embryos irrespective of mutation, we also analysed a total of 114 wild type embryos, obtained from 41 of the 42 mutant lines ( [Table 1](#T1){ref-type="table"}). Previous large-scale studies of wild type E14.5 embryos from the same genetic background have enabled us to distinguish normal variation in structure from definite abnormalities, using careful stage-specific comparisons combined with statistical and morphometric analysis ^[@ref-8]^. This formed the basis for identifying phenotypes in the wild type embryos ( [Table 2B](#T2b){ref-type="table"} and [Supplementary Table 1B](#ST1a){ref-type="other"} and [Supplementary Table 5](#ST5){ref-type="other"}).

###### Frequency of phenotypes identified in wild type embryos.

The Mammalian Phenotype Ontology terms describing phenotypes observed in each embryo were normalised to remove duplicates and the list then ranked in descending order by frequency of embryos exhibiting each phenotype.

  -----------------------------------------------------------
  MP ID        MP term                            Frequency
  ------------ ---------------------------------- -----------
  MP:0002169   no abnormal phenotype\             78
               detected                           

  MP:0013971   blood in lymph vessels             5

  MP:0011493   double ureter                      4

  MP:0013852   abnormal Mullerian duct\           3
               topology                           

  MP:0000783   abnormal forebrain morphology      3

  MP:0013876   absent ductus venosus valve        3

  MP:0013840   absent segment of posterior\       3
               cerebral artery                    

  MP:0011803   double kidney pelvis               3

  MP:0003826   abnormal Mullerian duct\           2
               morphology                         

  MP:0013877   abnormal ductus venosus valve\     2
               morphology                         

  MP:0006063   abnormal inferior vena cava\       2
               morphology                         

  MP:0014003   additional anastomosis between\    2
               intracranial vertebral arteries    

  MP:0003586   dilated ureter                     2

  MP:0011683   dual inferior vena cava            2

  MP:0014021   heterochrony                       2

  MP:0013851   abnormal Wolffian duct topology    1

  MP:0010595   abnormal aortic valve cusp\        1
               morphology                         

  MP:0002092   abnormal eye morphology            1

  MP:0003686   abnormal eye muscle\               1
               morphology                         

  MP:0000559   abnormal femur morphology          1

  MP:0013853   abnormal hepatic portal vein\      1
               formation                          

  MP:0000703   abnormal thymus morphology         1

  MP:0013970   absent connection between\         1
               subcutaneous lymph vessels\        
               and lymph sac                      

  MP:0013835   absent hypoglossal nerve           1

  MP:0000520   absent kidney                      1

  MP:0014006   absent posterior communicating\    1
               artery                             

  MP:0003722   absent ureter                      1

  MP:0006093   arteriovenous malformation         1

  MP:0010530   cerebral arteriovenous\            1
               malformation                       

  MP:0013813   dilated hepatic portal vein        1

  MP:0000602   enlarged liver sinusoidal spaces   1

  MP:0002989   small kidney                       1
  -----------------------------------------------------------

In total, 56 phenotype calls were made, affecting 32 of the wild type embryos and 28 of the 41 lines. 21 of the 56 phenotype calls (38%) are accounted for by only 6 embryos, (indicating the skewing effect of a small number of abnormal embryos). Most affected embryos showing only a single phenotype. This is in marked contrast to the finding of many different phenotypes in individual mutant embryos.

The phenotypes of wild types vary in character, ranging from apparently minor differences (e.g. in blood vessel morphology) to a few major abnormalities (e.g. absent kidney). Each one is rare amongst the population of wild type embryos analysed and affects only a single wild type embryo within the line. Only 10 phenotypes (15 phenotype calls) overlap between mutant embryos and their wild type siblings and these affect only 10 of the 41 lines for which wild type embryos have been assessed ( [Table 3](#T3){ref-type="table"}).

###### Overlap of identified phenotypes between homozygous mutant and wild type embryos within each line.

Mutant lines showing a phenotype shared by at least one homozygous mutant and one wild type embryo are listed, along with the MP term, its MP ID and it penetrance amongst the mutant and wildtype embryos. For each line where an overlap is identified, the ratio of shared phenotypes to the total number of unique phenotypes identified in mutant embryos is also presented.

  --------------------------------------------------------------------------------------------------------------------------------
  Allele                       Phenotypes shared by homozygous\     MP ID        Penetrance\   Penetrance\     Ratio of shared:\
                               mutants and wild type embryos                     in mutants    in wild types   total mutant\
                                                                                                               phenotypes
  ---------------------------- ------------------------------------ ------------ ------------- --------------- -------------------
  Adamts3\<tm1b(KOMP)Wtsi\>    abnormal forebrain morphology        MP:0000783   2/7           1/3             2/44

                               abnormal Mullerian duct topology     MP:0013852   1/7           1/3             

  Adcy9\<tm1b(EUCOMM)Wtsi\>    abnormal Mullerian duct morphology   MP:0003826   1/8           1/3             2/20

                               blood in lymph vessels               MP:0013971   1/8           1/3             

  Celf4\<tm1a(EUCOMM)Wtsi\>    blood in lymph vessels               MP:0013971   1/5           1/3             1/7

  Chtop\<tm1a(EUCOMM)Wtsi\>    abnormal forebrain morphology        MP:0000783   4/4           1/3             1/95

  Cir1\<tm3a(KOMP)Wtsi\>       additional anastomosis between\      MP:0014003   1/3           1/2             1/29
                               intracranial vertebral arteries                                                 

  Nsun2\<tm1a(EUCOMM)Wtsi\>    absent ductus venosus valve          MP:0013876   1/6           1/2             1/37

  Psph\<tm1a(EUCOMM)Hmgu\>     blood in lymph vessels               MP:0013971   1/8           1/3             1/109

  Tcf7l2\<tm1a(EUCOMM)Wtsi\>   absent ductus venosus valve          MP:0013876   2/5           1/4             3/32

                               enlarged liver sinusoidal spaces     MP:0000602   2/5           1/4             

                               abnormal eye muscle morphology       MP:0003686   3/5           1/4             

  Traf6\<tm2a(EUCOMM)Wtsi\>    blood in lymph vessels               MP:0013971   4/9           1/5             1/39

  Unk\<tm1a(KOMP)Wtsi\>        absent ureter                        MP:0003722   2/5           1/2             2/10

                               absent kidney                        MP:0000520   2/5           1/2             
  --------------------------------------------------------------------------------------------------------------------------------

Prevalence of individual abnormalities in mutant embryos
--------------------------------------------------------

[Supplementary Table 1A](#ST1a){ref-type="other"} presents the frequency of individual abnormalities that were identified amongst the mutant embryos. Since some phenotypes (such as vertebral abnormalities) are often present multiply in affected embryos, the data is normalised for occurrence by embryo. Interestingly, the most common phenotype detected in this study was subcutaneous edema. This was evident from macroscopic observation of embryos at harvest and confirmed by subsequent HREM imaging ( [Figure 3](#f3){ref-type="fig"}, panels A--C). In total, subcutaneous edema and edema in other body regions (scored with four distinct MP terms) affected one third (72/220) of the embryos and was observed in a little over half (24/42) of the mutant lines. Other prevalent phenotypes included defects affecting the vertebral arches, the ventricular septum of the heart, forebrain morphology and musculature of the developing eyes ( [Table 2A](#T2a){ref-type="table"} and [Figure 3](#f3){ref-type="fig"}). Of particular note is the frequency with which mutant embryos showed abnormalities affecting the architecture or presence of the hypoglossal nerve ( [Figure 4](#f4){ref-type="fig"}, panels A and B). Complete absence of the nerve occurred in 37 embryos, obtained from 12 different mutant lines, with some embryos from a similar number of lines showing abnormal topology or unusual thinness of the nerve (13 and 9 lines respectively). Overall, scored phenotypes affected all the major organ systems at E14.5 ( [Figure 5A](#f5){ref-type="fig"}) and multiple organs or tissues were frequently affected within individual embryos, or collectively within a mutant line ( [Figure 2](#f2){ref-type="fig"} and [Supplementary Figure 2](#SF2){ref-type="other"} and [Supplementary Figure 3](#SF3){ref-type="other"}). The complete listing of scored phenotypes is presented in [Supplementary Table 4](#ST4){ref-type="other"}, organised according to the MP ontology slims adopted by the DMDD, with data ranked according to prevalence in mutant lines.

![Individual mutant embryos show overlapping but distinct spectra of phenotypes.\
The phenotypes annotated for individual embryos were normalised to remove duplicate ontology terms. The distinct terms for each homozygous mutant embryo from four lines were then mapped onto the broad set of ontology categories defined in the high level DMDD slim. The presence or absence of phenotype annotation within each of the high level categories was plotted for each embryo analysed.](wellcomeopenres-1-11724-g0001){#f2}

![Examples of frequently observed abnormalities in mutant embryos.\
**A**-- **C**. Subcutaneous edema. Original HREM sections showing a massive (asterisk) ( **A**), mild ( **B**), and unilaterally located subcutaneous edema ( **C**). Note the shrinkage artefacts in **B** and **C**, which complicate post mortem diagnosis. **D**-- **F**. Perimembraneous septal defect. Normal situation in a control ( **D**) as appearing in an original HREM section. Defect (asterisk) as appearing in an original HREM section ( **E**) and a 3D volume model ( **F**). **G**-- **I**. Fusion of vertebral arches. Normal situation in a control ( **G**) as appearing in a sagittal section. Fused articular processes (arrowheads) of subsequent vertebrae in a sagittal ( **H**) and a coronal section ( **I**). **J**-- **L**. Abnormal eye muscle morphology as appearing in original HREM sections. Normal situation in a control ( **J**). Thinning of the lateral rectus muscle (lrm) ( **K**). Absence of the lateral rectus muscle (lrm) ( **L**). da, descending aorta; e, esophagus; g, adrenal gland; hb, hyoid bone; i, intestine; k, kidney; l, lung; la, left atrium; le, lens; li, liver; lrm, lateral rectus muscle; lv, left ventricle; lx, larynx; mrm, medial rectus muscle; oc, optic cup; on, optic nerve; ra, right atrium; rv, right ventricle; sc, spinal chord; t, tongue; tr, trachea; v, body of vertebra; va, arch of vertebra. Scale bars: 1 mm.](wellcomeopenres-1-11724-g0002){#f3}

![Other frequently observed abnormalities in mutant embryos.\
**A** and **B**. Abnormal hyopglossal nerve in original HREM sections through the head of *Prrc2b ^-/-^* ( **A**) and a *Polb ^-/-^* ( **B**) embryo. Note the missing right hypoglossal nerve (arrowhead, inlay) in **A** and the thinning of both hypoglossal nerves (hn) in **B**. **C**-- **E**. Abnormalities that also occur in controls. Persisting craniopharnygeal duct (arrowhead) as appearing in sagittal sections ( **C**). Split tip of tail featured by volume models ( **D**) and vesicles (arrowheads) in the lens (le) as appearing in an original HREM section ( **E**).](wellcomeopenres-1-11724-g0003){#f4}

![Variable prevalence and penetrance of individual phenotypes in mutant embryos.\
Data from the global analysis of the frequency of phenotype terms (see Materials and Methods) was plotted to show the number of lines falling into each of the observed phenotype categories. The colours indicate the number of lines falling into each of the distinct penetrance categories. The data was ordered according to line frequency, and subsequently by the numbers seen in the penetrance categories. ( **A**) shows the phenotype annotations summarised using the high level DMDD ontology slim, ( **B**) shows the phenotype annotations summarised using the intermediate level DMDD ontology slim.](wellcomeopenres-1-11724-g0004){#f5}

Individual phenotypes show highly variable penetrance
-----------------------------------------------------

Perhaps the most striking finding of the DMDD study is the almost complete absence of any fully penetrant abnormalities. Amongst lines for which more than a single embryo was analysed, only three phenotypes showed 100% penetrance: abnormal perichondrial ossification (1 line; 10 mutant embryos), small nodose ganglion (1 line; 4 embryos) and small trigeminal ganglion (1 line, 3 embryos). Furthermore, most defects showed surprisingly low penetrance. A penetrance greater than 75% within the line was only found for 7% of detected phenotypes. In contrast, over half (55%) of the scored abnormalities had a penetrance of 25% or less ( [Table 4](#T4){ref-type="table"}). This is graphically illustrated in [Figure 5A](#f5){ref-type="fig"}, in which the scored phenotypes are clustered according to high level MP ontology terms (broadly reflecting distinct organ systems, tissues or body regions) and the prevalence of each in the 42 mutant lines categorised by penetrance. All phenotypes show a broad range of penetrance, about half showing roughly symmetrical distribution of penetrance, with similar numbers of lines both above and below 50%. Interestingly, it is possible also to distinguish several phenotypes where penetrance is noticeably skewed. Abnormalities affecting the cardiovascular system, nervous system and skeleton all affected a relatively large number of lines and each showed a striking bias towards higher penetrance values. A second group of abnormalities encompassing liver/biliary, respiratory, renal and hearing systems showed a converse bias to penetrance values below 50% ( [Figure 5A](#f5){ref-type="fig"}).

###### Variability in mutant phenotype penetrance.

Every distinct phenotype scored in each line was listed along with its penetrance (i.e. the number of embryos showing the phenotype divided by the total number of embryos analysed for that line). Scored phenotypes were then ranked by penetrance value to obtain the proportions falling within the four ranges shown. (Note that all data from the lines *Otud7b*, *Npat* and *Dhx35* were removed from the analysis, since in each case, these were obtained from examination of a single embryo).

  --------------------------------------------------
  Penetrance range   Phenotypes scored\     \%
                     (homozygous mutants)   
  ------------------ ---------------------- --------
  \<25%              673                    55.21%

  26--50%            343                    28.14%

  51--75%            118                    9.68%

  \>75%              85                     6.97%
  --------------------------------------------------

###### High level MP ontology slim used by DMDD.

A list of the Mammalian Phenotype Ontology IDs and names of terms selected as the high level ontology slim.

  ------------ ------------------------------------
  MP:0002169   no abnormal phenotype detected
  MP:0005375   adipose tissue phenotype
  MP:0005386   behavior/neurological phenotype
  MP:0005385   cardiovascular system phenotype
  MP:0005384   cellular phenotype
  MP:0005382   craniofacial phenotype
  MP:0005381   digestive/alimentary phenotype
  MP:0005380   embryogenesis phenotype
  MP:0005379   endocrine/exocrine gland phenotype
  MP:0005378   growth/size/body region phenotype
  MP:0005377   hearing/vestibular/ear phenotype
  MP:0005397   hematopoietic system phenotype
  MP:0005376   homeostasis/metabolism phenotype
  MP:0005387   immune system phenotype
  MP:0010771   integument phenotype
  MP:0005371   limbs/digits/tail phenotype
  MP:0005370   liver/biliary system phenotype
  MP:0010768   mortality/aging
  MP:0005369   muscle phenotype
  MP:0003631   nervous system phenotype
  MP:0001186   pigmentation phenotype
  MP:0005367   renal/urinary system phenotype
  MP:0005389   reproductive system phenotype
  MP:0005388   respiratory system phenotype
  MP:0005390   skeleton phenotype
  MP:0005394   taste/olfaction phenotype
  MP:0002006   tumorigenesis
  MP:0005391   vision/eye phenotype
  ------------ ------------------------------------

###### Intermediate level MP ontology slim used by DMDD.

A list of the Mammalian Phenotype Ontology IDs and names of terms selected as the intermediate level ontology slim.

  ------------ --------------------------------------------------
  MP:0000001   mammalian phenotype

  MP:0002873   normal phenotype

  MP:0002169   no abnormal phenotype detected

  MP:0005375   adipose tissue phenotype

  MP:0000003   abnormal adipose tissue morphology

  MP:0005666   abnormal adipose tissue physiology

  MP:0004924   abnormal behavior

  MP:0020222   abnormal alertness

  MP:0011275   abnormal behavioral response to light

  MP:0009745   abnormal behavioral response to xenobiotic

  MP:0001502   abnormal circadian rhythm

  MP:0002069   abnormal consumption behavior

  MP:0002572   abnormal emotion/affect behavior

  MP:0001440   abnormal grooming behavior

  MP:0010698   abnormal impulsive behavior control

  MP:0002063   abnormal learning/memory/conditioning

  MP:0002066   abnormal motor capabilities/coordination/\
               movement

  MP:0002067   abnormal sensory capabilities/reflexes/\
               nociception

  MP:0011396   abnormal sleep behavior

  MP:0002557   abnormal social/conspecific interaction

  MP:0001529   abnormal vocalization

  MP:0002822   catalepsy

  MP:0002899   fatigue

  MP:0002064   seizures

  MP:0002127   abnormal cardiovascular system morphology

  MP:0001614   abnormal blood vessel morphology

  MP:0002925   abnormal cardiovascular development

  MP:0000266   abnormal heart morphology

  MP:0003279   aneurysm

  MP:0013332   peliosis

  MP:0001544   abnormal cardiovascular system physiology

  MP:0002128   abnormal blood circulation

  MP:0010695   abnormal blood pressure regulation

  MP:0000249   abnormal blood vessel physiology

  MP:0004039   abnormal cardiac cell glucose uptake

  MP:0002972   abnormal cardiac muscle contractility

  MP:0004084   abnormal cardiac muscle relaxation

  MP:0011926   abnormal cardiac valve physiology

  MP:0011390   abnormal fetal cardiomyocyte physiology

  MP:0011925   abnormal heart echocardiography feature

  MP:0008775   abnormal heart ventricle pressure

  MP:0004085   abnormal heartbeat

  MP:0003137   abnormal impulse conducting system\
               conduction

  MP:0020095   abnormal mean heart rate adaptation

  MP:0004215   abnormal myocardial fiber physiology

  MP:0003547   abnormal pulmonary pressure

  MP:0020092   abnormal susceptibility to aortic cartilaginous\
               metaplasia

  MP:0020098   abnormal susceptibility to diet-induced aortic\
               fatty streak lesions

  MP:0000230   abnormal systemic arterial blood pressure

  MP:0004484   altered response of heart to induced stress

  MP:0000343   altered response to myocardial infarction

  MP:0005330   cardiomyopathy

  MP:0006138   congestive heart failure

  MP:0001853   heart inflammation

  MP:0003328   portal hypertension

  MP:0005384   cellular phenotype

  MP:0000358   abnormal cell morphology

  MP:0005621   abnormal cell physiology

  MP:0013258   abnormal extracellular matrix morphology

  MP:0003121   genetic imprinting

  MP:0005382   craniofacial phenotype

  MP:0000428   abnormal craniofacial morphology

  MP:0002116   abnormal craniofacial bone morphology

  MP:0003935   abnormal craniofacial development

  MP:0003743   abnormal facial morphology

  MP:0011495   abnormal head shape

  MP:0002177   abnormal outer ear morphology

  MP:0005381   digestive/alimentary phenotype

  MP:0000462   abnormal digestive system morphology

  MP:0001663   abnormal digestive system physiology

  MP:0005380   embryogenesis phenotype

  MP:0001672   abnormal embryogenesis/development

  MP:0002084   abnormal developmental patterning

  MP:0001697   abnormal embryo size

  MP:0002085   abnormal embryonic tissue morphology

  MP:0008926   abnormal anterior definitive endoderm\
               morphology

  MP:0013230   abnormal cervical sinus morphology

  MP:0003085   abnormal egg cylinder morphology

  MP:0010115   abnormal embryonic cloaca morphology

  MP:3000001   abnormal gastrula morphology

  MP:0011411   abnormal gonadal ridge morphology

  MP:0011257   abnormal head fold morphology

  MP:0011260   abnormal head mesenchyme morphology

  MP:0012187   abnormal intraembryonic coelom morphology

  MP:0005650   abnormal limb bud morphology

  MP:0006301   abnormal mesenchyme morphology

  MP:0008487   abnormal mesonephros morphology

  MP:0011256   abnormal neural fold morphology

  MP:0005657   abnormal neural plate morphology

  MP:0002151   abnormal neural tube morphology/\
               development

  MP:0002825   abnormal notochord morphology

  MP:0002884   abnormal pharyngeal arch morphology

  MP:0013231   abnormal pharyngeal groove morphology

  MP:0013232   abnormal pharyngeal membrane morphology

  MP:0006031   abnormal pharyngeal pouch morphology

  MP:0012496   abnormal pleuropericardial membrane\
               morphology

  MP:0002399   abnormal pluripotent precursor cell\
               morphology/development

  MP:0013217   abnormal posterior definitive endoderm\
               morphology

  MP:0003885   abnormal rostral-caudal body axis extension

  MP:0012252   abnormal septum transversum morphology

  MP:0001688   abnormal somite development

  MP:0002861   abnormal tail bud morphology

  MP:0011258   abnormal tail fold morphology

  MP:0001674   abnormal triploblastic development

  MP:0011835   abnormal urogenital fold morphology

  MP:0011853   abnormal urorectal septum morphology

  MP:0003988   disorganized embryonic tissue

  MP:0013241   embryo tissue necrosis

  MP:0008932   abnormal embryonic tissue physiology

  MP:0003890   abnormal embryonic-extraembryonic\
               boundary morphology

  MP:0002086   abnormal extraembryonic tissue morphology

  MP:0001726   abnormal allantois morphology

  MP:0005029   abnormal amnion morphology

  MP:0011199   abnormal amniotic cavity morphology

  MP:0002836   abnormal chorion morphology

  MP:0011202   abnormal ectoplacental cavity morphology

  MP:0003396   abnormal embryonic hematopoiesis

  MP:0011200   abnormal extraembryonic coelom morphology

  MP:0010736   abnormal extraembryonic ectoderm\
               morphology

  MP:0001724   abnormal extraembryonic endoderm\
               formation

  MP:0006323   abnormal extraembryonic mesoderm\
               development

  MP:0011203   abnormal parietal yolk sac morphology

  MP:0001711   abnormal placenta morphology

  MP:0011197   abnormal proamniotic cavity morphology

  MP:0001725   abnormal umbilical cord morphology

  MP:0011201   abnormal visceral yolk sac cavity morphology

  MP:0001718   abnormal visceral yolk sac morphology

  MP:0003229   abnormal vitelline vasculature morphology

  MP:0002582   disorganized extraembryonic tissue

  MP:0004264   abnormal extraembryonic tissue physiology

  MP:0004966   abnormal inner cell mass proliferation

  MP:0009781   abnormal preimplantation embryo\
               development

  MP:0011186   abnormal visceral endoderm morphology

  MP:0012028   abnormal visceral endoderm physiology

  MP:0001730   embryonic growth arrest

  MP:0003984   embryonic growth retardation

  MP:0005379   endocrine/exocrine gland phenotype

  MP:0002163   abnormal gland morphology

  MP:0002164   abnormal gland physiology

  MP:0005378   growth/size/body region phenotype

  MP:0009701   abnormal birth body size

  MP:0005451   abnormal body composition

  MP:0003385   abnormal body wall morphology

  MP:0004134   abnormal chest morphology

  MP:0000432   abnormal head morphology

  MP:0012719   abnormal neck morphology

  MP:0002089   abnormal postnatal growth/weight/body size

  MP:0004196   abnormal prenatal growth/weight/body size

  MP:0001270   distended abdomen

  MP:0004133   heterotaxia

  MP:0013328   visceromegaly

  MP:0005377   hearing/vestibular/ear phenotype

  MP:0002102   abnormal ear morphology

  MP:0003938   abnormal ear development

  MP:0000026   abnormal inner ear morphology

  MP:0000049   abnormal middle ear morphology

  MP:0002177   abnormal outer ear morphology

  MP:0003878   abnormal ear physiology

  MP:0005397   hematopoietic system phenotype

  MP:0002396   abnormal hematopoietic system morphology/\
               development

  MP:0002429   abnormal blood cell morphology/development

  MP:0002398   abnormal bone marrow cell morphology/\
               development

  MP:0004808   abnormal hematopoietic stem cell morphology

  MP:0000689   abnormal spleen morphology

  MP:0000703   abnormal thymus morphology

  MP:0001545   abnormal hematopoietic system physiology

  MP:0005376   homeostasis/metabolism phenotype

  MP:0001764   abnormal homeostasis

  MP:0005266   abnormal metabolism

  MP:0008872   abnormal physiological response to\
               xenobiotic

  MP:0005164   abnormal response to injury

  MP:0000604   amyloidosis

  MP:0013027   wounding

  MP:0005387   immune system phenotype

  MP:0000685   abnormal immune system morphology

  MP:0000716   abnormal immune system cell morphology

  MP:0002722   abnormal immune system organ morphology

  MP:0001879   abnormal lymphatic vessel morphology

  MP:0001790   abnormal immune system physiology

  MP:0010771   integument phenotype

  MP:0010678   abnormal skin adnexa morphology

  MP:0010680   abnormal skin adnexa physiology

  MP:0002060   abnormal skin morphology

  MP:0005501   abnormal skin physiology

  MP:0001968   abnormal touch/nociception

  MP:0005371   limbs/digits/tail phenotype

  MP:0002109   abnormal limb morphology

  MP:0000572   abnormal autopod morphology

  MP:0000550   abnormal forelimb morphology

  MP:0000556   abnormal hindlimb morphology

  MP:0002115   abnormal limb bone morphology

  MP:0006279   abnormal limb development

  MP:0012000   abnormal limb position

  MP:0000549   absent limbs

  MP:0008985   hemimelia

  MP:0013069   limb wound

  MP:0000548   long limbs

  MP:0013133   pale limbs

  MP:0000547   short limbs

  MP:0020288   supernumerary limbs

  MP:0002111   abnormal tail morphology

  MP:0005370   liver/biliary system phenotype

  MP:0002138   abnormal hepatobiliary system morphology

  MP:0005083   abnormal biliary tract morphology

  MP:0003943   abnormal hepatobiliary system development

  MP:0000598   abnormal liver morphology

  MP:0010040   abnormal oval cell morphology

  MP:0002139   abnormal hepatobiliary system physiology

  MP:0010768   mortality/aging

  MP:0005369   muscle phenotype

  MP:0002108   abnormal muscle morphology

  MP:0002106   abnormal muscle physiology

  MP:0003631   nervous system phenotype

  MP:0003632   abnormal nervous system morphology

  MP:0002751   abnormal autonomic nervous system\
               morphology

  MP:0002152   abnormal brain morphology

  MP:0002653   abnormal ependyma morphology

  MP:0003634   abnormal glial cell morphology

  MP:0002184   abnormal innervation

  MP:0005623   abnormal meninges morphology

  MP:0003861   abnormal nervous system\
               development

  MP:0000778   abnormal nervous system tract morphology

  MP:0002882   abnormal neuron morphology

  MP:0002752   abnormal somatic nervous system morphology

  MP:0000955   abnormal spinal cord morphology

  MP:0008493   alpha-synuclein inclusion body

  MP:0003329   amyloid beta deposits

  MP:0012260   encephalomeningocele

  MP:0002229   neurodegeneration

  MP:0003012   no phenotypic analysis

  MP:0005395   other phenotype

  MP:0001186   pigmentation phenotype

  MP:0005367   renal/urinary system phenotype

  MP:0000516   abnormal renal/urinary system morphology

  MP:0011782   abnormal internal urethral orifice morphology

  MP:0002135   abnormal kidney morphology

  MP:0005187   abnormal penis morphology

  MP:0000534   abnormal ureter morphology

  MP:0011487   abnormal ureteropelvic junction morphology

  MP:0011488   abnormal ureterovesical junction morphology

  MP:0000537   abnormal urethra morphology

  MP:0000538   abnormal urinary bladder morphology

  MP:0003942   abnormal urinary system development

  MP:0003630   abnormal urothelium morphology

  MP:0003129   persistent cloaca

  MP:0005360   urolithiasis

  MP:0005502   abnormal renal/urinary system physiology

  MP:0003633   abnormal nervous system physiology

  MP:0005389   reproductive system phenotype

  MP:0002160   abnormal reproductive system morphology

  MP:0001119   abnormal female reproductive system\
               morphology

  MP:0001929   abnormal gametogenesis

  MP:0005149   abnormal gubernaculum morphology

  MP:0003673   abnormal inguinal canal morphology

  MP:0001145   abnormal male reproductive system\
               morphology

  MP:0003315   abnormal perineum morphology

  MP:0003936   abnormal reproductive system development

  MP:0002210   abnormal sex determination

  MP:0000653   abnormal sex gland morphology

  MP:0013055   genital wound

  MP:0001919   abnormal reproductive system physiology

  MP:0005388   respiratory system phenotype

  MP:0002132   abnormal respiratory system morphology

  MP:0002249   abnormal larynx morphology

  MP:0001175   abnormal lung morphology

  MP:0002233   abnormal nose morphology

  MP:0002240   abnormal paranasal sinus morphology

  MP:0002234   abnormal pharynx morphology

  MP:0010820   abnormal pleura morphology

  MP:0012684   abnormal pleural cavity morphology

  MP:0010942   abnormal respiratory epithelium morphology

  MP:0003115   abnormal respiratory system development

  MP:0002282   abnormal trachea morphology

  MP:0002133   abnormal respiratory system physiology

  MP:0005390   skeleton phenotype

  MP:0005508   abnormal skeleton morphology

  MP:0009250   abnormal appendicular skeleton morphology

  MP:0002114   abnormal axial skeleton morphology

  MP:0003795   abnormal bone structure

  MP:0000163   abnormal cartilage morphology

  MP:0011849   abnormal clitoral bone morphology

  MP:0002932   abnormal joint morphology

  MP:0005504   abnormal ligament morphology

  MP:0006322   abnormal perichondrium morphology

  MP:0002113   abnormal skeleton development

  MP:0005503   abnormal tendon morphology

  MP:0000566   synostosis

  MP:0001533   abnormal skeleton physiology

  MP:0005394   taste/olfaction phenotype

  MP:0005500   abnormal gustatory system morphology

  MP:0001002   abnormal taste bud morphology

  MP:0001985   abnormal gustatory system physiology

  MP:0005499   abnormal olfactory system morphology

  MP:0006292   abnormal nasal placode morphology

  MP:0008789   abnormal olfactory epithelium morphology

  MP:0012067   abnormal olfactory gland morphology

  MP:0001983   abnormal olfactory system physiology

  MP:0002006   tumorigenesis

  MP:0005391   vision/eye phenotype

  MP:0002092   abnormal eye morphology

  MP:0005193   abnormal anterior eye segment morphology

  MP:0001286   abnormal eye development

  MP:0001299   abnormal eye distance/position

  MP:0003686   abnormal eye muscle morphology

  MP:0001324   abnormal eye pigmentation

  MP:0002697   abnormal eye size

  MP:0001340   abnormal eyelid morphology

  MP:0008968   abnormal lacrimal apparatus morphology

  MP:0010030   abnormal orbit morphology

  MP:0005195   abnormal posterior eye segment morphology

  MP:0002698   abnormal sclera morphology

  MP:0005197   abnormal uvea morphology

  MP:0001293   anophthalmia

  MP:0006209   calcified intraocular region

  MP:0013146   eye lesions

  MP:0009859   eye opacity

  MP:0013170   eye swellings

  MP:0006225   ocular rupture

  MP:0001788   periorbital edema

  MP:0005254   strabismus

  MP:0005253   abnormal eye physiology
  ------------ --------------------------------------------------

###### New MP terms derived from embryo phenotyping.

A list of the Mammalian Phenotype Ontology IDs along with their corresponding term name. These have been added to the ontology to allow annotation of abnormalities observed in the embryos which could not be adequately described by existing terms.

  ------------ -------------------------------------------------
  MP:0013809   absent pectinate muscle

               

  MP:0013810   absent brachiocephalic trunk

  MP:0013812   enlarged orbital veins

  MP:0013813   dilated hepatic portal vein

  MP:0013814   abnormal hepatic portal vein connection

  MP:0013816   absent digastric muscle

  MP:0013817   absent nasal cavity

  MP:0013818   abnormal oral cavity morphology

  MP:0013819   abnormal acromioclavicular joint morphology

  MP:0013820   absent optic cup

  MP:0013823   absent segment of anterior cerebral artery

  MP:0013825   small hypoglossal canal

  MP:0013826   absent hypoglossal canal

  MP:0013827   thin oculomotor nerve

  MP:0013828   thin facial nerve

  MP:0013829   thin splanchnic nerve

  MP:0013830   abnormal intrathoracic topology of vagus\
               nerve

  MP:0013831   vagus nerve compression

  MP:0013832   thin vagus nerve

  MP:0013833   absent olfactory nerve

  MP:0013834   thin hypoglossal nerve

  MP:0013835   absent hypoglossal nerve

  MP:0013836   abnormal hypoglossal nerve topology

  MP:0013837   abnormal vagus nerve topology

  MP:0013838   small caudate nucleus

  MP:0013840   absent segment of posterior cerebral artery

  MP:0013841   abnormal lymphatic vessel topology

  MP:0013842   ductus venosus stenosis

  MP:0013843   hepatic portal vein stenosis

  MP:0013844   abnormal perichondrial ossification

  MP:0013845   abnormal eye muscle topology

  MP:0013846   retropharyngeal edema

  MP:0013847   retropleural edema

  MP:0013848   subcutaneous edema

  MP:0013849   absent abducens nerve

  MP:0013850   absent posterior commissure

  MP:0013851   abnormal Wolffian duct topology

  MP:0013852   abnormal Mullerian duct topology

  MP:0013853   abnormal hepatic portal vein formation

  MP:0013855   absent celiac artery

  MP:0013857   abnormal abdominal muscle morphology

  MP:0013858   abnormal azygos vein topology

  MP:0013859   abnormal vitelline vein connection

  MP:0013860   anastomosis between common carotid and\
               vertebral artery

  MP:0013861   abnormal pancreas topology

  MP:0013862   abnormal cecum position

  MP:0013864   enlarged paraumbilical vein

  MP:0013865   abnormal dorsal pancreas topology

  MP:0013868   abnormal ventral pancreas topology

  MP:0013869   vascular diverticulum

  MP:0013870   absent proximal internal carotid artery\
               segment

  MP:0013871   abnormal stapedial artery topology

  MP:0013873   abnormal ductus venosus morphology

  MP:0013874   abnormal ductus venosus topology

  MP:0013875   trigeminal neuroma

  MP:0013876   absent ductus venosus valve

  MP:0013877   abnormal ductus venosus valve morphology

  MP:0013878   abnormal ductus venosus valve topology

  MP:0013879   duplication of ductus venosus

  MP:0013880   absent ductus venosus

  MP:0013913   absent rib-vertebral column attachment

  MP:0013914   absent intracranial segment of vertebral artery

  MP:0013915   abnormal brachial plexus formation

  MP:0013916   decreased intestine length

  MP:0013917   persistent right 6th pharyngeal arch artery

  MP:0013918   abnormal endolymphatic sac topology

  MP:0013923   small prevertebral sympathetic ganglia

  MP:0013924   abnormal dural venous sinus morphology

  MP:0013925   abnormal vascular plexus formation

  MP:0013926   absent neurohypophysis

  MP:0013927   abnormal facial nerve topology

  MP:0013928   thin motoric part of trigeminal nerve

  MP:0013929   absent eye muscles

  MP:0013930   abnormal digastric muscle connection

  MP:0013931   abnormal olfactory bulb position

  MP:0013932   fragmented Meckel\'s cartilage

  MP:0013933   short Meckel\'s cartilage

  MP:0013934   supratentorial ventricles enlargement

  MP:0013935   basal brain tissue herniation

  MP:0013936   abnormal thymus topology

  MP:0013937   absent lobe of thyroid gland

  MP:0013938   abnormal esophagus topology

  MP:0013943   abnormal ureter topology

  MP:0013944   persistent cloacal membrane

  MP:0013945   abnormal elbow joint morphology

  MP:0013946   abnormal perirectal tissue morphology

  MP:0013947   abnormal paraaortic body morphology

  MP:0013948   intraembryonal intestine elongation

  MP:0013949   fusion of axis and occipital bones

  MP:0013950   abnormal dorsal root ganglion topology

  MP:0013951   abnormal descending aorta topology

  MP:0013952   retro-esophageal left subclavian artery

  MP:0013953   left sided brachiocephalic trunk

  MP:0013963   jugular vein stenosis

  MP:0013964   absent tongue muscles

  MP:0013965   abnormally deep median sulcus of tongue

  MP:0013967   abnormal infrahyoid muscle connection

  MP:0013968   multiple persisting craniopharyngeal ducts

  MP:0013969   reduced sympathetic cervical ganglion size

  MP:0013970   absent connection between subcutaneous\
               lymph vessels and lymph sac

  MP:0013971   blood in lymph vessels

  MP:0013972   occipital vertebra

  MP:0013973   abnormal hepatic vein connection

  MP:0013974   abnormal coronary vein connection

  MP:0013975   abnormal coronary sinus connection

  MP:0013976   abnormal left vena cava superior connection

  MP:0013977   symmetric azygos veins

  MP:0013978   abnormal carotid artery origin

  MP:0013979   abnormal subclavian artery origin

  MP:0013980   abnormal pulmonary artery origin

  MP:0013981   double lumen aortic arch

  MP:0013982   inverse situs of great intrathoracic arteries

  MP:0013984   abnormal superior mesenterial vein\
               connection

  MP:0013985   abnormal umbilical vein topology

  MP:0013986   abnormal vitelline vein topology

  MP:0013987   absent intrahepatic inferior vena cava\
               segment

  MP:0013988   absent portal vein segment

  MP:0013989   symmetric hepatic veins

  MP:0013991   abnormal common iliac artery origin

  MP:0013992   persistent dorsal ophthalmic artery

  MP:0013993   anastomosis between basilar artery and\
               common carotid artery

  MP:0013994   abnormal parasellar internal carotid artery\
               branch morphology

  MP:0013995   abnormal external carotid artery origin

  MP:0013996   abnormal vertebral artery origin

  MP:0013997   abnormal internal carotid artery topology

  MP:0013998   absent canalicular internal carotid artery\
               segment

  MP:0013999   absent parasellar internal carotid artery

  MP:0014000   anastomosis between internal carotid artery\
               and basilar artery

  MP:0014001   abnormal vertebral artery topology

  MP:0014002   absent extracranial vertebral artery segment

  MP:0014003   additional anastomosis between intracranial\
               vertebral arteries

  MP:0014004   absent basilar artery segment

  MP:0014006   absent posterior communicating artery

  MP:0014008   absent labyrinthine artery

  MP:0014009   anastomosis between middle cerebral arteries

  MP:0014011   abnormal ovary tissue architecture

  MP:0014017   abnormal Wolffian duct connection

  MP:0014018   embryo tumor

  MP:0014019   embryo cyst

  MP:0014020   intramural bleeding in blood vessel wall

  MP:0014021   heterochrony

  MP:0014022   abnormal duodenum topology
  ------------ -------------------------------------------------

When grouped into such high level MP ontology terms, the most common group of abnormalities are those affecting the cardiovascular system, examples of which affect embryos in every single mutant line studied. Almost as prevalent are nervous system phenotypes, which are detected in 80% of the lines studied. Re-plotting the data summarised by intermediate level MP term slim provides a more detailed view of the prevalence and variability in penetrance of phenotypes ( [Figure 5B](#f5){ref-type="fig"}). At this level of resolution, for example, cardiovascular defects are subdivided into two broad categories; those encompassing abnormalities in blood vessel morphology or topology ("abnormal blood vessel morphology" and most phenotypes within "abnormal cardiovascular development") and those affecting the heart and its great vessels ("abnormal heart morphology"). Viewed in this way, it is clear that detection of cardiovascular defects in all lines examined results from the presence of phenotypes in the vasculature. These range from relatively major defects such as absence of the ductus venosus, interrupted aortic arch or arterial stenosis, to more minor alterations in vascular topology in different regions of the embryo. Cardiac abnormalities nevertheless remain prevalent, affecting almost two thirds (27/42) of the mutant lines. These encompass malformations in all regions of the four-chambered heart and its great vessels, including both atrial and ventricular septal defects, atrioventricular septal defects, common arterial trunk, double outlet right ventricle, transposition of the great arteries, bicuspid aortic valve, common truncal valve and abnormally thin myocardium. After blood vessel and cardiac abnormalities, the third most prevalent group of phenotypes detected were those affecting brain morphology ( [Figure 5B](#f5){ref-type="fig"}), most commonly the forebrain ( [Figure 6](#f6){ref-type="fig"} and [Supplementary Table 1A](#ST1a){ref-type="other"}).

![Abnormal brain morphology phenotypes.\
**A** and **B**. Tissue protrusion (pr) into the 3rd ventricle (III) in an original HREM-section ( **A**) and a volume model ( **B**). Inlay in **B** shows normal situation in a control. **C**. Irregular tissue protrusions (arrowheads) on the brain surface in a *4933434E20Rik ^-/-^* embryo. **D**. Abnormal tissue (arrowhead) at the cortex near the lateral sulcus in a *Polb ^-/-^* embryo. **E**. Abnormal frontal wall of the lateral ventricles in a *H13 ^-/-^* embryo. **F**. Abnormal morphology and tissue architecture (arrowhead) of the frontal forebrain in a *Chtop ^-/-^* embryo. **G**. Abnormal morphology of the wall of the 3rd ventricle and protrusions (arrowhead) on the surface of the diencephalon in a *Brd2 ^-/-^* embryo. ah, adenohypophysis; f, forebrain; h, hindbrain; ie, inner ear; oc, optic cup; pr, tissue protrusion; tg, trigeminal ganglion; III, 3rd ventricle; Scale bars 1 mm.](wellcomeopenres-1-11724-g0005){#f6}

In order to assess the relative significance of each phenotype in the context of variable penetrance, we re-examined their ranking distribution after weighting each phenotype according to its individual prevalence. This provides a plot of cumulative line penetrance for each of the 70 intermediate level MP term slim ( [Figure 7](#f7){ref-type="fig"}). Whilst abnormalities in blood vessel morphology and structure of the heart remain amongst the most prevalent phenotypes, weighting by penetrance has a significant impact on the ranking of other phenotypes. Notably, the relative ranking of "abnormal brain morphology" and "abnormal somatic nervous system morphology" is increased, with both now lying in the five most prevalent abnormalities scored. This change is largely driven by the relatively high prevalence associated with abnormalities in forebrain morphology and hypoglossal nerve structure or presence, respectively.

![Cumulative penetrance of individual phenotypes in mutant embryos.\
Data from the global analysis of the frequency of phenotype terms (see Materials and Methods) was plotted to show the cumulative penetrance score for each of the phenotype categories observed (i.e. the overall sum of the penetrance scores recorded for the lines showing the phenotype). The Mammalian Phenotype Ontology terms assigned during embryo phenotyping were summarised using the intermediate level DMDD ontology slim, and the data was ordered according to the cumulative penetrance score. The colours indicate the contribution of lines falling into each of the distinct penetrance categories to the cumulative penetrance score.](wellcomeopenres-1-11724-g0006){#f7}

Phenotype penetrance is affected by allele type
-----------------------------------------------

Of the 42 mutant lines studied, 22 contained the tm1a insertion allele, compared with 20 containing exon deletions (19 tm1b and 1 CRISPR). With either group, blood vessel, heart and brain morphology remain amongst the most commonly observed abnormalities. There is however a clear difference in phenotype penetrance between the two groups: phenotypes are significantly less penetrant with tm1a alleles (compare [Figure 5B](#f5){ref-type="fig"} with [Figure 8A and B](#f8){ref-type="fig"}).

![Influence of allele type on prevalence and penetrance of individual phenotypes in mutant embryos.\
Data from the global analysis of the frequency of phenotype terms shown in [Figure 5A](#f5){ref-type="fig"} was subdivided by allele type to compare tm1a ( [Figure 8A](#f8){ref-type="fig"}) and tm1b ( [Figure 8B](#f8){ref-type="fig"}) alleles. Data is summarised using the intermediate level ontology slim and colours indicate the number of lines falling into each of the distinct penetrance categories. The data was ordered according to line frequency and subsequently by numbers seen in the penetrance categories.](wellcomeopenres-1-11724-g0007){#f8}

Phenotyping embryos required new MP terms
-----------------------------------------

Adoption of a formal, standardised ontology for scoring abnormalities provides an essential framework for analysing the data and facilitating structured search enquiries. However, during the course of the DMDD programme and its pilot study ^[@ref-9]^, it became clear that additional terms were required in order to adequately describe abnormalities in embryo, as opposed to adult structures. A further outcome of the DMDD study has therefore been the creation of 142 new MP terms to accommodate the range of abnormalities we have observed ( [Table 7](#T7){ref-type="table"}). These include, for example, thin motoric part of the trigeminal nerve (MP:0013928; <http://www.ontobee.org/ontology/MP?iri=http://purl.obolibrary.org/obo/MP_0013928>), blood in lymph vessels (MP:0013971; <http://www.ontobee.org/ontology/MP?iri=http://purl.obolibrary.org/obo/MP_0013971>), double lumen aortic arch (MP:0013981; <http://www.ontobee.org/ontology/MP?iri=http://purl.obolibrary.org/obo/MP_0013981>), abnormal elbow joint morphology (MP:0013945; <http://www.ontobee.org/ontology/MP?iri=http://purl.obolibrary.org/obo/MP_0013945>), and intramural bleeding in blood vessel wall (MP:0014020; <http://www.ontobee.org/ontology/MP?iri=http://purl.obolibrary.org/obo/MP_0014020>) ( [Figure 9](#f9){ref-type="fig"}).

![Examples of new MP phenotypes.\
**A**-- **C**. "Thin motoric part of trigeminal nerve". Original HREM sections through the head of a *Polb ^-/-^* embryo ( **A**, **B**) and a control ( **C**). Box in A indicates section displayed in **B**. **D** "Blood in lymph vessels", as appearing in an original HREM section through the neck of a *1700067K01Rik ^-/-^* embryo. Note the blood filled left lymph sac (asterisk). Use the right sided lymph sac (rls) as a control. **E**. Double lumen aortic arch. Surface model of the great intrathoracic arteries on top of an original HREM section of a *Pdzk1 ^-/-^* embryo. (Compare with [@ref-17]). **F**. "Intramural bleeding in blood vessel wall" (arrowhead) in the descending aorta (da) of an *Akap9 ^-/-^* embryo from the DMDD pilot study ^[@ref-9]^. Coronal section through a volume model. **G**-- **H**. "Abnormal elbow joint morphology" Sagittal sections. Normal situation in a control ( **G**). Fusion of humerus (h) und ulna material (u) in an *Atp11a ^-/-^* embryo. aa, aortic arch; ah, adenohypophysis; bt, brachiocephalic trunk; da, descending aorta; dlaa, double lumen aortic arch; e, esophagus; h, humerus; l, lung; la, left atrium; lcc, left common carotid artery; le, lens; lsa, left subclavian artery; lx, larynx; mp, motoric part of trigeminal nerve; nc, nasal cavity; oc, optic cup; r, radius; ra, right atrium; rcc, right common carotid artery; rv, right ventricle; sc, spinal chord; tg, trigeminal ganglion; u, ulna; v, vertrebral body; III, 3rd ventricle; Scale bars: 1 mm.](wellcomeopenres-1-11724-g0008){#f9}

Discussion
==========

Since approximately one third of gene knockouts in the mouse prove to be embryonic or perinatal lethal ^[@ref-1]--\ [@ref-3]^, further study of such lines offers a unique opportunity to better understand the genetic regulation of embryo development and identify genetic determinants of congenital abnormalities. The data accumulated during three years of the DMDD programme provide the first opportunity to study in detail the identity, range and prevalence of morphological abnormalities in such mutants and offer a window on the opportunities (and pitfalls) such systematic studies present.

The current analysis is restricted to a single developmental stage (E14.5) when most organ systems of the embryo have developed their definitive fetal appearance and the body plan is broadly similar to that of the adult mouse. Whilst this provides obvious practical advantages for a systematic, high throughput phenotyping programme, it is of course an arbitrary choice with respect to the time course of individual gene function and the consequences of gene ablation. Indeed, about 60% of the lethal lines entering the DMDD pipeline fail to provide homozygous mutant offspring by E14.5, with half of those causing lethality prior to E9.5 \[see also [@ref-2]\]. The data here therefore comes from a subset of lethal lines. Furthermore, phenotypes observed at a single time point most likely combine more immediate consequences of individual gene loss with more distant or secondary consequences. Teasing out the role of regulative or compensatory changes from primary effects of gene loss is likely to be difficult. Despite these caveats, there are, nevertheless, several striking findings that emerge from detailed phenotype analysis.

Our finding that some manifestation of edema (generally subcutaneous) is the most common phenotype could indicate an unappreciated complexity in the genetic controls regulating fluid balance or tissue integrity of vascular or lymphatic components. Edema may also represent a common outcome for a wide range of pathophysiological perturbations, as has been proposed for the association of non-immune hydrops fetalis with human fetal loss ^[@ref-11],\ [@ref-12]^. The prevalence of cardiovascular defects is also consistent with the well established finding that cardiac abnormalities are the most common congenital defect in human newborns ^[@ref-13]^. Some caution is necessary in considering the mouse data, since as we have shown, a significant proportion of cardiovascular phenotypes comprise apparently minor alterations in blood vessel topology, the impact of which on normal development remains unclear. However, in addition to these, the lines we have studied show a range of severe abnormalities in cardiac structure that are both relatively prevalent and mirror the range of congenital abnormalities seen in humans. Despite the largely random selection of genes studied in screens such as DMDD, their identification as embryonic lethal therefore provides a dramatic enrichment for potential cardiac developmental disease alleles.

Phenotypes affecting neural tissue also prove to be relatively prevalent in mutant embryos. We are limited in the present analysis to identifying a subset of neural deficits readily identified from HREM imaging. This restricts identifiable phenotypes to relatively gross alterations in brain and neural tube morphology, or changes affecting major nerves. Amongst the latter, the frequency with which abnormalities affecting the hypoglossal nerve have been detected is perhaps not so surprising, since these (like abnormalities detected in the motoric portion of the trigeminal nerve) may compromise suckling and lead to perinatal lethality.

The multiplicity of phenotypes frequently detected in individual mutant embryos is not unexpected, given the nature of a single time point screening procedure, combined with the likely pleiotropic effects of individual gene loss. However, the most striking and surprising finding to emerge from the DMDD phenotype data is that virtually all phenotypes are incompletely (and frequently poorly) penetrant, despite the use of the isogenic C57BL/6N mouse strain. Combined with the observation of overlapping but distinct spectra of phenotypes between individual embryos from a single line, these findings are challenging to understand, and at a minimum point towards unknown stochastic components affecting the etiology of each phenotype or the compensatory responses they elicit ^[@ref-2]^. They also demonstrate that efforts to identify linkage between mouse embryo phenotypes and human developmental disease are likely to require sophisticated bioinformatic analysis beyond the obvious issues raised by species differences in anatomy and physiology.

The observation of a small number of phenotypes amongst the wild type litter mates of the homozygous mutants raises the important question: why are phenotypes detected in genetically wild type embryos? We think there are several possible explanations. One possibility is that the C57BL/6N mouse strain used for engineering knockout lines carries a "background load" of abnormalities, previously unappreciated. Ours is the first systematic study on sufficiently large scale and employing sufficiently high-resolution imaging to detect such abnormalities. None of the phenotypes we have identified show a high penetrance across both mutants and wild types of a mutant line and do not therefore suggest themselves as strain-specific abnormalities. Another possible explanation is that abnormalities arise as a consequence of *de novo* mutation. Lastly, at least with the less profound abnormalities, it is possible that some phenotypes may prove to be outliers on spectrum of normal morphological variation and should not be considered genuine abnormalities. This highlights an important issue confronting phenotyping studies: the dearth of large-scale and systematic studies examining normal embryo morphology that can set a reliable benchmark for distinguishing abnormalities from normal variation. In this light, phenotype data may need revision as cumulative experience with the C57BL/6N and other mouse strains improves our ability to distinguish abnormalities from normal variation amongst wild types.

Our study has identified a small number of apparent abnormalities common to both homozygous mutant embryos and wild-type controls from the C57BL/6N mouse strain and which have therefore been excluded from the phenotyping procedure. These include splitting of the tail tip, persistence of the craniopharyngeal duct with associated fenestration of head bones and the presence of vesicles in the lens of the eye ( [Figure 4](#f4){ref-type="fig"}, panels C--E). Apart from these, our data offers no clear evidence for other "background" phenotypes associated with either the C57BL/6N genetic background or with individual mutant lines. Overall, we consider that neither the frequency, prevalence nor nature of the phenotypes identified in wild type embryos impact significantly on the assignation of phenotypes amongst the homozygous mutant embryos.

Two other factors in our study might affect interpretation of the mutant phenotype data. 11 of the 42 lines examined in our study were judged subviable at weaning, rather than lethal. This number is too small to support meaningful comparison of the phenotypic spectrum between subviables and lethals. It is tempting to speculate that a difference in phenotype penetrance might underlie the difference in viability between the two groups, but there is no evidence to support this from the DMDD study so far (see [Supplementary Figure 4](#SF4){ref-type="other"}). Even if a difference in penetrance was detected between lethal and subviable lines, interpreting its significance is far from simple as it raises an important and unresolved question: which phenotypes are responsible for embryo death? Many profound abnormalities that we detect may be compatible with life; equally, lethality may result from subtle structural changes. Without knowing which of the scored phenotypes are likely to cause lethality, it will be difficult, if not impossible, to establish if differences in their penetrance distinguish subviable from lethal lines. Add to this the additional difficulty that dams have a propensity to eat newborns that are not thriving well and there is a further complication in interpreting the data.

The lines we have studied fall roughly equally between those containing an insertion into the targeted gene (tm1a alleles) and those in which recombination has removed both a gene exon and the neomycin selection cassette (tm1b alleles). Interestingly, our data clearly reveals that tm1b alleles show greater penetrance of phenotypes than those containing the tm1a insertion. This may reflect the potential of tm1a alleles to be hypomorphic, and might also be influenced by their retention of the neo selection cassette.

It is also worth noting the several practical lessons which have become evident through the course of DMDD studies and which may be of value for similar embryo phenotyping programmes. The most pressing of these is basing phenotype detection on comparison of each mutant embryo with an appropriately staged normal counterpart ^[@ref-14]^. Embryos harvested at E14.5 vary markedly in their developmental progress and many tissues and organs are actively remodelled during this period. This is most obvious for the topology of the intestine, the position of the palatal shelves and the interventricular communication between left and right sides of the heart. Only with precise developmental staging is accurate phenotyping of these features possible ^[@ref-8]^.

Whilst the precise range and detail of phenotypes that can be scored will necessarily be dictated by the nature of the imaging modality and the method of phenotype identification (compare, for example [@ref-15], [@ref-16], with the manual annotation used in the present study), a common challenge is the development of protocols to minimise occurrence or subsequent scoring of apparent abnormalities that are more likely artefacts of sample preparation or processing. These can range from the more obvious ruptures of the embryo skin or damaged external features during dissection, to tissue shrinkage or swelling (causing organ deformation) as a result of dehydration, fixation or embedding. Finally, the power of phenotypic screens such as DMDD to inform our understanding of developmental disease rests heavily on the detail with which abnormalities are scored. However, the very complexity we have seen this generates makes it all the more urgent to distinguish phenotypes not just through the nature of the morphological abnormality, but through its capacity, individually or in concert with others, to compromise subsequent fetal survival.

Data availability
=================

Dataset 1 Zenodo: [10.5281/zenodo.163506](http://dx.doi.org/10.5281/zenodo.163506) ^[@ref-18]^

Dataset 2 Zenodo: [10.5281/zenodo.268899](http://dx.doi.org/10.5281/zenodo.268899) ^[@ref-19]^

The cumulative list of all scored phenotypes analysed in this study is presented in Dataset 1 (homozygous mutants) and Dataset 2 (wild type embryos). The intermediate and high level slims of the MP ontology used in the analysis are presented in [Supplementary table 2](#ST2){ref-type="other"} and [Supplementary Table 3](#ST3){ref-type="other"}. All data used in this study is also available from the DMDD web site ( <https://dmdd.org.uk>) where phenotype annotations are available in tabular format by embryo and by line. In addition, they are identified at their appropriate locations within each 3D dataset of embryo images, which can be viewed in all three orthogonal section planes.

We are grateful for the contributions made by past and present members of the DMDD consortium and the support of their institutions, without which the DMDD programme would not be possible.

Supplementary material
======================

**Supplementary Figure 1: Embryo Homozygous mutant embryo numbers analysed for each mutant line.**

The number of annotated embryos scored for each of the 42 lines was used to plot the variation in numbers of embryos analysed per line.

Click here for additional data file.

**Supplementary Figure 2: Distribution of homozygous mutant embryo phenotypes amongst DMDD mutant lines (high level MP ontology slim).**

Data from the global analysis of the frequency of phenotype terms (see Materials and Methods) is plotted to show the penetrance of phenotypes scored for each line, indicated by a colour gradient from light yellow (no penetrance) to dark red (100% penetrance). Each line is labelled after the symbol of the gene disrupted (see also [Table 1](#T1){ref-type="table"}), and the number of homozygous mutant embryos analysed for each line is shown. Phenotype annotations are summarised using the high level DMDD ontology slim.

Click here for additional data file.

**Supplementary Figure 3: Distribution of homozygous mutant embryo phenotypes amongst DMDD mutant lines (intermediate level MP ontology slim).**

As in [Supplementary Figure 2](#SF2){ref-type="other"}, except that phenotype annotations are summarised using the intermediate level DMDD ontology slim.

Click here for additional data file.

*Supplementary Figure 4: Penetrance of mutant embryo phenotypes in lethal and subviable mutant lines*.

Data from the global analysis of the frequency of phenotype terms (see Materials and Methods) was plotted using embryos of the same genetic background ( *C57BL/6N;C57BL/6NTac*) to show the number of lines falling into each of the observed phenotype categories (using the MP ontology intermediate slim). Each of the distinct penetrance categories is colour coded and data is ordered according to line frequency. (A) shows the penetrance distribution in the combination of lethal and subviable lines; (B) shows the equivalent plot for lethal lines alone.

Click here for additional data file.

**Supplementary Table 1A and 1B: Embryo phenotypes, organised by frequency.**

The data from the global analysis of the frequency of phenotype terms (see Materials and methods) is presented in a structured fashion showing the relationship between Mammalian Phenotype Ontology terms included in the DMDD high level ontology slim, the DMDD intermediate level ontology slim, and the original annotation terms. The first three columns list the ID, term and frequency of DMDD high level ontology slim terms, columns 4--6 list the ID, term and frequency of the intermediate level ontology slim terms that cluster under the high level term listed in column 1, and for each intermediate level term the annotation phenotype terms are shown in order of frequency in columns 7--9. Column 10 lists the lines in which the phenotype listed in columns 7 was observed. The table rows are ordered according to the frequency of the high level ontology terms, intermediate ontology terms and original annotation terms. [Table 1A](#ST1a){ref-type="other"}: homozygous mutant embryos; [Table 1B](#ST1b){ref-type="other"}: wildtype embryos.

Table 1A:

Click here for additional data file.

Table 1B:

Click here for additional data file.

*Supplementary Table 2: High level MP ontology slim used by DMDD.*

A list of the Mammalian Phenotype Ontology IDs and names of terms selected as the high level ontology slim.

Click here for additional data file.

*Supplementary Table 3: Intermediate level MP ontology slim used by DMDD.*

A list of the Mammalian Phenotype Ontology IDs and names of terms selected as the intermediate level ontology slim.

Click here for additional data file.

*Supplementary Tables 4 and 5: All embryo phenotypes from lethal and sub-viable lines scored by DMDD to date.*

The tables list the annotation data that is the basis of the study. For every annotation the gene symbol, MGI_ID, allele symbol, DMDD_ID, MP term, ID and name is listed. In some cases the same MP term is listed more than once for a specific embryo (DMDD_ID), indicating the phenotypic abnormality was observed more than once in that embryo.

Supplementary Table 4: homozygous mutant embryos

Click here for additional data file.

Supplementary Table 5: wild type embryos

Click here for additional data file.
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The Deciphering Mechanisms of Developmental Disorders consortium presents a systematic study of the morphology of mutant embryos from 42 lines developed in the frame of the International Phenotyping Consortium. The lines chosen for this study were selected as they are homozygous lethal or subviable at weaning but viable at E14.5.

The authors employ High Resolution Episcopic Microscopy to capture 3D images of the embryos, providing exquisitely detailed documentation of embryo morphologies. They exploit this rich dataset with a systematic and in depth annotation of morphological defects which they record using appropriate levels of MP terms.

The result is a survey of impressive scope in terms of annotation depth and volume of data, and a superb effort of data organisation and analysis so the great complexity of the dataset can be distilled to overall observations and discussion points. This organisation effort yielded a really useful framework for systematic analysis of the morphology of mouse mutant of that stage.

The authors conclude that a salient point of the work is the great variability of penetrance of the morphological phenotypes they find among these mutant embryos of the same isogenic genetic background.

Although the variable expressivity of phenotype between different individuals of a same mutant line isn't a new concept, the unexpected result of the study is the extend to which phenotypes (even when grouped in broad categories such as "organ affected") vary in penetrance, albeit that these mutants share the broadest of phenotype which is lethality.

However, the authors restrict their analysis to the variability amongst mutants and they mention in the discussion an on-going systematic analysis of WT embryos, which will provide key information to put in context the observations collated in this article.

Whereas the article is an excellent effort of presenting a complex dataset with clarity and granularity and documenting variability of morphology amongst samples, the data presented do not allow the reader to identify the reason(s) of this variability in the absence of key information. Three major points should be addressed: The authors made the unusual choice of not presenting baseline data on the morphology of wild-type mutants (littermates) produced in the study. Such data, surveying significant groups of control embryos, would be essential to establish the link between mutations and described phenotypes. In the absence of this data, any reference to a causal link between phenotypes and mutation should be removed from the article.Both targeted traps (tm1a) and null (tm1b and CRISPR induced deletions) alleles are employed in the study. Both the presence of a selection cassette and the unpredictability of efficiency of trapping cassette(s) could form the basis of at least some of the variability shown in this study. An evaluation of variability (particularly using slim terms) within each of these 2 groups of alleles would help to address this point.Subviable lines show by definition a partially penetrant phenotype and contribute to a quarter of the mutant studied. An evaluation of variability (particularly using slim terms) within lethal and subviable as separate alleles groups would discriminate whether variability of morphology is particularly occurring among subviable lines.  

Minor points: Methods should detail information that permit the appraisal of materials used in the study, detailing the genetic background of stem cells and animals employed for germline transmission, and further breeding, including whether homozygotes were used to produce embryos to analyse subviable lines.Methods should outline the steps taken to limit manual annotation variability (i.e. secondary calling or benchmarking between annotators).All titles and text should precisely detail when lethal or both lethal and subviable mutations are presented.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Mohun
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**The authors made the unusual choice of not presenting baseline data on the morphology of wild-type mutants (littermates) produced in the study. Such data, surveying significant groups of control embryos, would be essential to establish the link between mutations and described phenotypes. In the absence of this data, any reference to a causal link between phenotypes and mutation should be removed from the article.**

We have included the wild type phenotype data in the revised version of the manuscript (see the detailed response to Rosenthal/Murray for more details).

**Both targeted traps (tm1a) and null (tm1b and CRISPR induced deletions) alleles are employed in the study. Both the presence of a selection cassette and the unpredictability of efficiency of trapping cassette(s) could form the basis of at least some of the variability shown in this study. An evaluation of variability (particularly using slim terms) within each of these 2 groups of alleles would help to address this point.**

The revised manuscript now includes separate analysis of phenotypes for the 22 tm1a alleles compared with 20 complete nulls (19 tm1b and 1 CRISPR). With either allele, blood vessel, heart and brain morphology remain amongst the most commonly observed abnormalities. However, with such relatively small numbers, we feel there is little more that can usefully be concluded from comparison of individual phenotype prevalence, since this will be heavily influenced by the distinct gene identities within each allele group. In contrast, there is a clear difference in phenotype penetrance between the two groups: phenotypes are clearly more penetrant from tm1b alleles (see new Figure 8A and 8B). We presume that this reflects the fact that whilst mutations based on tm1a alleles have the potential to be hypomorphic, those converted from tm1a to tm1b contain an exon deletion (and no longer carry the neo selection cassette).

**Subviable lines show by definition a partially penetrant phenotype and contribute to a quarter of the mutant studied. An evaluation of variability (particularly using slim terms) within lethal and subviable as separate alleles groups would discriminate whether variability of morphology is particularly occurring among subviable lines.**

We presume that the reviewer is wondering whether the difference between lethal and subviable lines is a result of differing degrees of penetrance of phenotypes that result in embryo death. Answering this point is not as simple as it might appear as it touches on a much more profound issue raised by studies such as ours. Whilst we are able to distinguish a remarkable number of different structural abnormalities by virtue of the resolution HREM imaging affords, it may not be at all clear which of these results in embryo lethality. Many profound abnormalities may be compatible with life and lethality may also result from structurally subtle changes. Without knowing which of the scored phenotypes are likely to cause lethality, it will be difficult if not impossible to establish of differences in their penetrance distinguish subviable from lethal lines. Add to this the additional difficulty that dams have a propensity to eat newborns that are not thriving well and there is a further complication in interpreting the data.

We have nevertheless reexamined the phenotype data in order to compare the results separately for lethal and subviable lines (new Supplementary Figure 4). From this it is clear that there is insufficient data from subviable lines to draw unequivocal conclusions. Overall, the approximate prevalence of particular phenotype terms (using the intermediate slim) appears broadly similar to that of lethals, but for most of these, the numbers of affected lines are too few to make useful estimates of penetrance.

**Minor points:**

1\. Full details of genetic background and mutant allele are now provided for each line (revised Table 1).

2\. All phenotyping was performed according to a standardised and sequential procedure, as mentioned in Material and methods. The data from each embryo was independently reviewed by a second anatomist and any discrepancies resolved by joint agreement.

3\. We have amended titles and text to ensure that the distinction between lethal and subviable lines is clear where necessary.
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This manuscript describes the findings of the DMDD consortium, analyzing 42 lethal and subviable genes at E14.5 using high-resolution 3D imaging (HREM) coupled with detailed annotation of the specific phenotypes revealed. The level of granularity in the scoring of the phenotypes is a major strength of the paper, and reflects the deep and unique expertise of the team. This has facilitated the discovery of widespread variable penetrance in mutant embryos at a level of detail not previously described. Furthermore, the effort to organize the MP into a series of "slims" is quite useful for organizing the calls into easier to analyze groups, and such work will likely benefit other groups such as the IMPC. 

The manuscript is clearly written and, importantly, goes to great lengths to ensure full access to all data. In addition to minor issues detailed below, there are two major gaps, however, that must be addressed. There is no description of the number of control embryos screened or the incidental rate of hits for each phenotype in the DMDD list. Given the focus of the paper on the variability of phenotype penetrance and the number of phenotypes with an "n=1", it is impossible to draw conclusions without this information. While the authors allude to a manuscript in preparation, it is actually essential data for this paper.Similarly, there is no description of how the authors account for global developmental delay in mutants, which can lead to many "phenotypes" that are merely the result of slowed/retarded development or variability in developmental timing between litters. For example, at E14.5, one would expect a high rate of cleft palate in mutants that have some level of overall delay, or in entire delayed litters, as the palate is elevating and fusing at that time point. This raises the following questions: are controls from each litter collected? How is uniform staging assured? Are "delayed" embryos compared to a stage-matched control? Again, the authors allude to another manuscript, but some of this information needs to be included here to assure the MP calls do not have trivial explanations.  

Minor points:  While the brief description of the animal resource and use of website citation is acceptable, given the main finding of variable penetrance, the authors should make a point of describing the isogenic genetic background and the nature of the alleles (tm1a or tm1b) in the methods and results.It's not entirely clear if this was a set of 42 genes that were lethal/subviable at wean, or if this was a select set of lethal genes that were viable/subviable (present) at E14.5. Given the comments in the discussion about lines lethal at E9.5 or earlier, I assume the latter. This should be spelled out.Mouse gene symbols should be italicized.Apart from Table 1, the tables are too large and make reading a PDF a somewhat painful process. These might not be easily compressed, so most of the information should be moved to a supplemental file.

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.

Mohun
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The Francis Crick Institute, UK
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**There is no description of the number of control embryos screened or the incidental rate of hits for each phenotype in the DMDD list. Given the focus of the paper on the variability of phenotype penetrance and the number of phenotypes with an "n=1", it is impossible to draw conclusions without this information. While the authors allude to a manuscript in preparation, it is actually essential data for this paper.**

The revised manuscript now includes the complete phenotype data obtained for 114 wild type embryos. This comprises 56 phenotype calls, affecting 32 embryos, originating from 28 lines (revised Tables 1, 2B and Supplementary Table 5). 21 of the 56 phenotype calls (38%) are accounted for by only 6 embryos, (indicating the skewing effect of a small number of abnormal embryos), most affected embryos showing only a single phenotype. This is in marked contrast to the finding of many different phenotypes in individual mutant embryos. The phenotypes of wild types vary in character, ranging from apparently minor differences (e.g. in blood vessel morphology) to a few major abnormalities (e.g. absent kidney). Each one is rare amongst the population of wild type embryos analysed and affects only a single wild type embryo within the line. Only 10 phenotypes (15 phenotype calls) overlap between mutant embryos and their wild type siblings and these affect only 10 of the 41 lines for which wild type embryos have been assessed (Table 3). As we discuss in the revised Results and Discussion sections, these data raise 3 related questions: Why are phenotypes detected in genetically wild type embryos? Are there "background" phenotypes associated with the C57BL/6N line that contribute to the mutant phenotypes scored? Is there any evidence for "background" phenotypes associated with an individual knockout line?

We think there are several possible explanations for finding phenotypes amongst wild type embryos. One possibility is that the mouse strain that has been used for engineering knockout lines carries a "background load" of abnormalities, previously unappreciated. Ours is the first systematic study on sufficiently large scale and employing sufficiently high resolution imaging to detect such abnormalities. Amongst the phenotypes identified, none shows significant prevalence that might be expected if it was a strain-specific abnormality. Another possible explanation is that abnormalities arise as a consequence of de novo mutation and the frequency we detect reflects the high sensitivity that results from HREM imaging. Lastly, at least with the less apparently severe abnormalities, it is possible that some of these in fact represent outliers on spectrum of normal morphological variation and should not be considered genuine abnormalities. This highlights an important issue confronting phenotyping studies: the dearth of large-scale and systematic studies examining normal embryo morphology that can set a reliable benchmark for distinguishing abnormalities from normal variation. In this light, phenotype data may need revision as cumulative experience improves our ability to distinguish abnormalities from variation amongst wild types.

Whatever the explanation, it is clear that neither the frequency, prevalence nor nature of the phenotypes identified in wild type embryos impact significantly on the assignation of phenotypes amongst the homozygous mutant embryos.

**Similarly, there is no description of how the authors account for global developmental delay in mutants, which can lead to many "phenotypes" that are merely the result of slowed/retarded development or variability in developmental timing between litters. For example, at E14.5, one would expect a high rate of cleft palate in mutants that have some level of overall delay, or in entire delayed litters, as the palate is elevating and fusing at that time point. This raises the following questions: are controls from each litter collected? How is uniform staging assured? Are "delayed" embryos compared to a stage-matched control? Again, the authors allude to another manuscript, but some of this information needs to be included here to assure the MP calls do not have trivial explanations.**

We believe it is important to distinguish between the effect of precise developmental stage of phenotyping and the issue of developmental retardation or delay. We can now reference the published study we mentioned that addresses these very questions (Geyer et al. 2017, J. Anat. in press). We do indeed collect wild type controls from each litter but our experience has demonstrated that precise stage matching of mutants with controls is essential to underpin accurate phenotyping. To facilitate this, we have analysed a large number of wild type embryos from the same genetic background as the that used for engineering of mutant lines. We have developed a system that can reliably distinguish five sub-stages within the span of Theiler stages 21 to 22 that are collected during E14.5, enabling us to compare each mutant embryo against precise, developmental stage-matched controls. Careful study and comparison of these has identified those changes (such as fusion of palatal shelves) which occur during the window of development that we observe. By combining qualitative comparisons with quantitative morphometry and statistical analysis, we are able to distinguish what can be considered genuine abnormalities from features that show either rapid developmental change or significant variability in the developmental timing of their appearance.

A more precise staging system also allows us to phenotype homozygous mutant embryos accurately, even though they frequently show some developmental delay, since we are able to compare them to controls at the equivalent stage of development. It also allows us to score instances of heterochrony where this affects individual (or a limited subset of) organs or tissues. By analysing a large number of wild type embryos harvested at E14.5, we have identified the spread and distribution of individual developmental sub stages that might be expected, and on this basis have a robust, statistical definition for global developmental retardation. Our studies do not allow us to identify why such retardation is relatively common amongst mutant embryos, but do offer some interesting pointers that we have commented upon. Retardation is, for example, much more common in mutant embryos showing cardiovascular defects (Geyer et al. 2017, J. Anat. in press). Furthermore, a surprisingly large proportion of mutants show abnormalities in their placental structure, and this may perhaps impact on their overall growth and development (unpublished data).

**Minor points**

1\. The genetic background and details of each allele are now included in revised Table 1. 39 of the 42 lines analysed are on an identical background (C57BL/6N;C57BL/6NTac). 22 lines contain the tm1a allele, 19 contain tm1b and 1 line was produced using CRISPR.

2\. The "Embryos" section of Materials and Methods details how the 42 lines were designated as lethal or subviable at wean (P14).

3\. Mouse gene symbols have been italicised.

4\. It was not possible for the larger tables to be moved to supplementary files; this is an unfortunate limitation of the online presentation method. Wellcome Open Research requested that the tables were included as figures rather than supplementary data and we agree that it is helpful for the reader to see the nature of the data. We had hoped that the individual files could also be downloaded in their spreadsheet format to allow full interrogation but the interface does not currently allow this. We have requested this change but in the meantime large tables are now also included in supplemental spreadsheet files to allow the reader to search and filter the data as required.
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We live in interesting times. Election outcomes are unpredictable. People are unpredictable and now as Wilson *et al.* report even the consequences of specific mutations are significantly less predictable than we might expect.

The Deciphering the Mechanisms of Developmental Disorders (DMDD) programme aims to analyse 240 embryonic lethal mouse knockout lines over a five-year period to study genes essential for mouse embryonic development and survival. This paper provides the first report on results gathered thus far. Wilson et al performed a detailed assessment of morphological abnormalities at stage E14.5 in 220 embryos from 42 novel mouse gene knockout lines. High Resolution Episcopic Microscopy was used to detect abnormalities at a scale from whole organs and tissues down to individual nerves and blood vessels. They report multiple abnormalities in virtually all of the embryos studied. They generated a wealth of information; in excess of 1.6 million images including more than 700,000 transverse sections to detail the incidence of structural abnormalities in 209 of the 220 embryos analysed. Eleven of the embryos from nine different lines were apparently normal.

To provide systematic phenotypic data Mammalian Phenotype (MP) ontology terms were used to classify abnormalities with high and intermediate levels. This allowed the authors to calculate a penetrance score for the terms in each of the mutant lines and to assign these to a quartile percentage group. Only 3 phenotypes were 100% penetrant and over half of the abnormalities had a penetrance score under 25%.    

Approximately one third of mouse gene knockouts are lethal and 60% of lethal lines entering the DMDD programme fail to provide homozygous mutant offspring by E14.5 with half of those being lethal prior to E9.5. Thus, as the authors point out, the data presented are from a subset of lethal lines. However, the most striking aspect of this study is the variability in penetrance of virtually all of the phenotypes analysed.

Recent studies sequencing human exome DNA has identified a high frequency of loss of function mutations. A study by Lek et al 2016 ^[@rep-ref-17602-1]^ examined more than 60,000 human exomes and reported predicted homozygous loss of function genotypes in 1775 genes. On average there are 35 homozygous gene deletions in each human. Thus the comment by Wilson et al in the present paper is particularly pertinent; relating these findings to human developmental disease will require further sophisticated analysis. It would appear that homozygous loss of function mutations are more common than previously realised and, furthermore, the consequences of loss of function mutations are much more variable than previously realised. It will not be trivial to unmask the causes of this variability. We are only just beginning to scratch the surface of understanding the consequences of loss of function mutations in both mice and humans.

I have only one minor suggestion. On p4 3 lines from the bottom, the sentence starting \"The Brd2 and Tcf712 alleles showed a similar, but less pronounced, conservation of phenotype..\" requires clarification. Do they mean similar to Atp11a, to each other, or to both?

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Mohun

Tim

The Francis Crick Institute, UK
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The sentence on p4 referenced in the reviewer\'s comment describes a trend in the similarity of phenotypes across all of the embryos within a particular mutant line. So we are not comparing the phenotypes between lines, but whether there is consistency between different embryos within any individual line.

[^1]: RR, JW, CT, CM, ET and AG identified lethal lines and provided embryos; EH, LF, AM, FP and TM carried out HREM imaging, SG, LR, JR, DS and WW identified phenotypes; RW performed data analysis; CMcG and RW designed and maintained the DMDD web portal; JS, ER and DA contributed to the design of the study; RW, SG, WW and TM prepared the manuscript. All authors were involved in the revision of the draft manuscript and have agreed to the final content.
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